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The relationship between transcription and replication has not been fully understood. 
In this study I aim to understand more about this relationship by making use of the 
EBV latent origin of replication oriP. OriP is able to initiate replication in the 
presence of the EBV protein EBNA-1 by recruiting the cellular replication machinery, 
therefore making it a suitable candidate for this study. Firstly, oriP was inserted onto a 
vector and placed under the transcriptional effect of a promoter at various locations 
within and without a transcriptional unit. The vectors were transfected into EBNA-1 
expressing cells and the replication assayed using Southern blot. In addition, total 
RNA was also extracted and analyzed using Northern blot. Southern blot results 
indicated that the presence of a promoter upstream of oriP displayed the strongest 
replication inhibition. Interestingly, Northern blot results indicated that there was a 
lack of oriP containing transcripts both in the presence and absence of EBNA-1, 
suggesting that oriP could have an inhibitory effect on transcription. In an attempt to 
confirm the inhibitory effect of oriP on transcription, in vitro transcription was 
performed, and results obtained were similar to those obtained in vivo. There were a 
few possible explanations for these observations. One of which was that transcription 
arrest occurred as the transcriptional machinery read through oriP. This state of 
transcriptional arrest would explain for the lack of oriP containing transcripts and at 
the same time; the physical stalling of the machinery along the template could have 
inhibited replication by preventing the replication initiation machinery from 
assembling on oriP. To test this possibility, we used size exclusion chromatography of 
in vitro transcription reactions to differentiate between arrested transcripts trapped 
with RNA polymerase and free transcripts. The results were consistent with the 
dissociation of transcription elongation complex at oriP. Thus, the hypothesis of 
 xiii
transcriptional arrest was not supported and the mechanism by which transcription 






































The interplay between DNA replication and transcription has long been a focal point 
of debate between researchers. Various works done by different groups have thrown 
up different observations and conclusions, each of them seemingly contradicting the 
other.  While some claim that transcription inhibits replication, others propose that 
transcription is necessary for replication. In this study we attempt to cast this 
relationship in better light by employing the use of a known viral origin of replication, 
the oriP, from the DNA herpesvirus, Epstein Barr Virus (EBV). But before we talk 
about the relationship between these two cellular processes, we should first look at 
them individually and examine what are some of the basic mechanisms that govern 
and control them.  
 
The bacterial DNA replication system was one of the pioneer models that contributed 
to our understanding of DNA replication (Jacob et al. 1963). In this model, it was 
proposed that two elements were required for the initiation of DNA replication: a 
replication initiator protein and a cis-acting DNA element. Only when the replication 
initiator protein binds to the cis-acting DNA element can DNA replication initiate and 
proceed. Further work employing the use of the bacterial chromosome finally 
elucidated this initiator protein to be a DNA binding protein called DnaA. Multiple 
binding sites for DnaA could be found on the cis-acting DNA element, identified as 
an origin of replication, oriC (Baker and Bell, 1998; Kornberg and Baker, 1992).  
 
So far, DNA replication system in simple eukaryotes such as Saccharomyces 
cerevisiae seems to bear some similar characteristics to the prokaryotic model in the 
sense that both require an initiator and a cis-acting DNA element. Both utilize a DNA 
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polymerase to synthesize the new strand of DNA from the template strand by adding 
nucleotides to the 3’-OH end. But that is where the similarities probably end. The 
complexity and the size of the eukaryotic genome far surpasses that of prokaryotes 
and the initiator protein consists of different proteins arranged in a complex, called the 
origin recognition complex (ORC) (Bell, 2002). And the difference is even more 
obvious in higher order eukaryotes. To solve the problem of having to replicate such a 
large genome, these eukaryotic organisms are also able to initiate DNA synthesis at 
multiple sites (Huberman and Riggs, 1968). Another major difference lies in the fact 
that DNA replication only occurs exclusively in the S phase of these higher order 
eukaryotic cell cycle as compared to prokaryotes, which occur throughout the 
bacterial life cycle. This would also mean that DNA replication in eukaryotes is more 
tightly regulated. 
 
Epstein-Barr Virus (EBV) is a DNA virus that exists as an extrachromosomal episome 
during its latent stage of infection. Its ability to persist in infected cells latently can be 
attributed to two viral components, the latent origin of replication oriP and the viral 
nuclear antigen, EBV Nuclear Antigen-1 (EBNA-1). OriP contains multiple EBNA-1 
binding sites, and with the help of bound EBNA-1, help recruit cellular proteins 
necessary for DNA replication. This enables the virus to replicate its genome together 
with the cell during the S phase, resulting in one copy of each viral replicon being 
produced per cell cycle (Kieff and Rickinson, 2001). In fact, this particular 
characteristic of the EBV has been employed in the construction of episomal gene 
therapy vectors. Episomal gene therapy vectors based on EBV already show great 
promise in treating disorders like Duchenne Muscular Dystrophy (Tsukamoto et al., 
1999). But for such vectors to be successful, efficient replication of the vector and the 
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expression of the therapeutic gene that is carried on the vector must occur. Therefore, 
a better understanding of the relationship between replication and transcription of an 
oriP-dependent episome is critical for the optimal design of such vectors. Therefore, 
the issue addressed in this work is of practical significance besides being an 
interesting subject in basic molecular biology and virology. 
 
Transcription in prokaryotes occurs in three main steps: initiation, elongation and 
termination. Initiation first occurs when the RNA polymerase complex binds to the 
promoter region. Elongation proceeds soon after with the RNA polymerase moving 
along the DNA template, adding ribonucleotides to the 3’-OH end of the forming 
RNA transcript and termination occurs when the RNA polymerase meets terminator 
sequences or when a termination signal protein binds to the RNA polymerase. In 
prokaryotes, one form of RNA polymerase is apparently responsible for the synthesis 
of all RNA.  
 
In eukaryotic cells, transcription also requires the three main steps as described for the 
prokaryotic system. However, it was further described that the initiation stage can be 
further broken down into another three distinct phases, namely the preinitiation, 
initiation and promoter clearance (Sims et al. 2006). Differences between prokaryotic 
and eukaryotic transcription systems also include the fact that the eukaryotic system 
possesses three different RNA polymerases instead of one. They are RNA polymerase 
I, RNA polymerase II and RNA polymerase III, each of which transcribe a different 
set of genes. Furthermore, post-transcriptional processing of the RNA transcript such 
as alternative splicing in eukaryotic cells allow for a larger repertoire of proteins to be 
synthesized from a single strand of  mRNA. 




As both transcription and replication utilize the same source of DNA template, there 
is the inevitable question of whether any conflicts between these two processes could 
arise. Indeed there have been works describing the physical collision between the 
RNA polymerase and DNA polymerase in bacterial cells (Brewer, 1988). Haase et al. 
(1994) have also shown that transcription through a known mammalian origin of 
replication inhibits the ability of the plasmid carrying the origin to replicate. A similar 
observation can also be extended to another eukaryotic organism, Saccharomyces 
cerevisiae, where transcription through the autonomously replicating sequences (ARS) 
inhibits the ability the ARS’s ability to activate replication (Tanaka et al., 1994).  
 
On the other hand, it has been known for some time that regions of chromatin that are 
transcriptionally active replicate earlier than transcriptionally inactive regions 
(Stambrook and Flickinger, 1970; Goldman et al., 1984; Taljanidisz et al., 1989; 
Gilbert, 2002). Genome-wide analysis of replication and transcription timing in 
Drosophila have drawn the conclusion that there exits a strong correlation between 
DNA replication and transcription (Schübeler et al., 2002; MacAlpine et al., 2004). 
Analysis studies done on the human genome have drawn very similar conclusions, 
providing a strong indication that transcription may be essential for replication 
(Woodfine et al. 2004; White et al. 2004). In addition, Boucher et al. (2004) have 
shown that transcription was required to ensure the replication and faithful 
partitioning of plasmids in Leishmania donavani. 
 
To aid our study of the relationship between replication and transcription, we decided 
to utilize the EBV latent origin of replication, oriP. In addition to the reason stated 
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above, oriP has also been shown, in the presence of EBNA-1 to recruit cellular 
replication machinery and this most likely allows the virus to replicate its genome 
during the latent stage of infection by recruiting the human origin recognition 
complex to the oriP (Chaudhuri et al., 2001; Dhar et al. 2001; Schepers et al. 2001). 
Therefore it is a suitable candidate for our study. We cloned oriP onto a vector 
containing a SV40 promoter in varying positions from the SV40 and transfected these 
clones into EBNA-1 expressing cells for a short term replication assay. Southern blot 
results indicated that vectors with oriP immediately downstream of the SV40 
promoter showed the most inhibition of replication, regardless of the orientation of 
the oriP. Total RNA was also analyzed to study if transcription through the oriP of 
these clones were affected as well. Interestingly, preliminary Northern blot results 
also indicated that the clones that exhibited the most replication inhibition also 
displayed the most inhibition of transcription through the oriP. 
 
These preliminary findings seem to indicate that the relationship between replication 
and transcription is a possibly one of a negative nature. One possible explanation was 
that for transcription to inhibit replication, the transcription complex would have to 
prevent the replication complex from assembling on the origin of replication. It could 
be possible that transcription was arrested at the origin of replication as the 
transcription complex transverses along the DNA template. This state of arrest would 
likely cause the complex to be immobilized and prevent the movement of other 
transcription complexes, resulting in the saturation of transcription complexes on the 
DNA template and preventing the initiation of replication. Transcriptional arrest 
would also explain the lack of oriP containing transcripts in the oriP containing 
vectors. If this hypothesis is proven to be correct, it could potentially offer a novel 
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method by which the persistence of episomal gene therapy vectors based on viruses 
such as the Epstein-Barr virus (EBV) can be regulated. 
 
To determine if inhibition of transcription was due to the physical arrest of the 
transcription complex on the DNA sequence, we attempted to isolate the complex 
with the arrested transcript using in-vitro transcription and size exclusion 
chromatography.  Preliminary in-vitro transcription experiments also indicated that 
transcription was also inhibited for clones containing oriP immediately downstream 
of the promoter. However, size exclusion chromatography failed to isolate any RNA 
polymerase-arrested transcript complex, indicating that there is most likely no form of 
physical arrest of the transcription complex on the DNA template.   
 
The failure to isolate any RNA polymerase-arrested transcript is an indication that 
termination of transcription rather than arrest most likely occurred as the transcription 
complex met the oriP. If that is the case, our stand that the arrest of the transcription 
complex along the DNA template prevents the DNA replication complex from 
recognizing and binding to the oriP, thereby inhibiting replication should be re-
examined. There are other potential directions that could be explored in the future to 
help in the further understanding of the interplay between transcription and DNA 
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2. Survey of Literature 
 
2.1 DNA replication 
DNA replication is a fundamental process in any living organism. It is also a highly 
complex procedure with different enzymes being involved at different stages of the 
process. There are three main stages for replication: initiation, elongation and 
termination. During initiation of replication, a protein complex first recognizes and 
binds to a site on the DNA template. The double-stranded parental DNA at that site is 
then separated into single strands, called the replication fork. Before elongation can 
occur, priming must first occur by the synthesis of a short RNA primer, a nick in 
DNA or a small priming protein. Elongation of the daughter DNA strand is carried 
out by the DNA polymerase bi-directionally and involves the addition of nucleotides 
to the growing 3’-OH end.  This results in a newly synthesized DNA strand being 
base-paired with the parental strand. This is also called semi-conservative DNA 
replication. Termination of replication usually occurs when replication is completed. 
Resolution of the replicated double stranded DNA from one another is required for 
further partitioning into daughter cells. This section will focus more on the initiation 
of replication. 
 
2.1.1 Prokaryotic DNA replication 
Prokaryotes usually contain only one replicon that exists as a closed circular DNA. 
One of the most extensively studied replication system in prokaryotes is in 
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2.1.1.1 Origin of replication in prokaryotes 
Jacob et al. (1963) first proposed the idea that for DNA replication in bacteria to 
proceed, two things are first required: a trans-acting initiator protein and a cis-acting 
element at which DNA replication starts. Initiation of replication in Escherichia coli 
occurs at a specific sequence of DNA in the replicon, known as oriC. OriC in turn 
contains multiple binding sites for the initiator protein DnaA, which was arranged as a 
huge multi-subunit protein complex surrounding oriC (Bramhill and Kornberg, 1988; 
Kornberg and Baker, 1992; Baker and Bell, 1998). The DnaA complex bound to oriC 
serves two purposes in replication: it first helps to unwind the surrounding DNA it is 
located on and it ultimately recruits helicases to the origin of replication via binding to 
loading factors. In Escherichia coli, the loading factors DnaC are found as a complex 
with DnaB, with six molecules of DnaC binding with six molecules of DnaB as a 
multimer. In this form, the bound DnaB is inactive for its helicase activity and only 
upon the binding of DnaC-DnaB complex to the DnaA, is DnaB released from DnaC 
in an ATP dependent manner (Wahle et al., 1989). DnaB further unwinds the DNA 
and at the same time activates a primase, DnaG, which synthesizes short RNA 
primers required for the DNA replication to proceed.  A representative diagram of 























Figure 1. Prokaryotic replication initiation. In prokaryotic replication initiation, 
DnaA first binds to oriC, resulting in local unwinding of double stranded DNA as 
symbolized by the bubble. Following that, DnaC and DnaB gets recruited to the origin. 
DnaC then dissociates from DnaB, leaving DnaB on the origin DNA. DnaB can act as 
a helicase, resulting in further unwinding of the origin DNA.  
 
2.1.2 Eukaryotic DNA replication 
In many ways, the eukaryotic replication is quite similar to the prokaryotes in the 
sense that they follow the same basic requirements: the presence of trans-acting 
initiator protein and a cis-acting DNA element. However, the size and complexity of 
the eukaryotic genome far surpasses the prokaryotic genome and the eukaryotic 
system possesses different and more sophisticated ways of regulating DNA 
replication. The following section will talk more on the origins of DNA replication in 
several eukaryotic organisms, from simple eukaryotes like Saccharomyces cerevisiae 
to higher eukaryotes like mammalians.  
 
   Legend  
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2.1.2.1 Origin of DNA replication in Saccharomyces cerevisiae 
One of the first origins of replication to be discovered in eukaryotes came from 
studies done on Saccharomyces cerevisiae. These origins of replication like the ones 
found in prokaryotes, were specific DNA sequences called autonomously replicating 
sequence (ARS). They were found in the chromosome and were shown to be able to 
confer to any plasmid the ability to exist extrachromosomally in yeast (Stinchcomb et 
al., 1979). The ARS was later shown to be able to bind to a replication initiator 
protein called the origin recognition complex (ORC), a multiprotein complex made up 
of six different subunits, (Bell and Stillman, 1992). And this ORC, together with 
another protein, Cdc6, help recruit other proteins to form a pre-replicative complex 
(pre-RC). 
 
Further study into the ARS identified four motifs within the ARS that was responsible 
for the binding to the ORC and essentially required for replication to occur: A, B1, B2 
and B3. The A element contains the ARS consensus sequence (ACS), which was an 
eleven base pair AT-rich sequence that exists in all known ARS, while the B elements 
were of varying sizes of ten to fifteen base pairs long that lie 5’ of the A element. 
Seemingly, the A element, while vital for the proper function of the ARS, requires at 
least one of the B elements to be found in the ARS for the origin to work (Marahrens 
and Stillman, 1992; Newlon and Theis, 1993; Rao and Stillman, 1995; Rowley et al., 
1995). 
 
The ORC is a six protein complex that binds to the ARS in an ATP dependent manner 
(Bell and Stillman, 1992). Out of the six subunits of the complex, Orc1p-6p, only 
Orc1p, Orc2p, Orc4p and Orc5p binds directly to the DNA at the AT-rich regions 
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found in the ACS. The ability of the ORC complex to bind to the DNA requires ATP 
to be bound to the Orc1p, and although ATP is hydrolyzed by Orc1p, it seems to serve 
a separate function (Klemm et al., 1997). Although Orc3p and Orc6p do not bind 
directly to the DNA, both are indispensable. Orc3p may be involved in arranging the 
other subunits for the proper binding to the origin (Lee and Bell, 1997). While Orc6p 
does not seem to play a role in affecting the DNA binding specificity of the complex 
to the DNA, it is still required for DNA replication and cell viability (Li and 
Herskowitz, 1993). 
 
After the binding of the ORC to the origin, other proteins like Cdc6, Cdt1 and the 
MCM  (minichromosome maintenance) complex are recruited to form the pre-
replicative complex. The Cdc6 was identified to be one of the first proteins to be 
recruited after the association of the ORC with the origin. It is believed to directly 
bind to the origin as well and in turn helps recruit the MCM complex to the chromatin 
in an ATP dependent manner, without which replication cannot proceed properly 
(Tanaka et al., 1997). While the role of Cdt1 in pre-RC formation is not well known, 
Tanaka and Diffley (2002) have shown that Cdt1 interacts directly with the MCM 
complex and accumulates in the nucleus during G1 phase, suggesting that the Cdt1 
could act as a carrier protein aiding in the localization of the MCM complex to the 
origin completing the pre-RC formation. The MCM complex is widely believed to be 
the helicase involved in unwinding double stranded DNA into single strand during 
DNA replication (Labib and Diffley, 2001). A representative diagram of replication 
initiation in eukaryotes is shown in figure 2 below. 
 
The purpose of assembling the pre-RC is to ultimately recruit DNA polymerases to 
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the origin for the purpose of DNA replication. However, for that to happen, additional 
factors apart from the pre-RC must be present as well. Cdc45 was one such example 
shown to be needed for the assembly of components necessary for DNA replication. It 
was found to associate with the MCM complex, replication protein A (RPA) as well 
as the DNA polymerases themselves, DNA polymerase α and ε (Aparicio et al., 1999; 
Zou and Stillman, 2000). It was suggested that the complex containing the Cdc45, 
MCM complex and RPA was involved in the unwinding and subsequent assembly of 











Figure 2. Eukaryotic replication initiation. In eukaryotes, the ORC first binds to 
DNA, followed by Cdc6. Cdt1 possibly guides the MCM complex to the Cdc6 bound 
ORC. Hydrolysis of ATP followed by the dissociation of Cdt1 and Cdc6 occurs, 
leaving the MCM together with the ORC on the DNA. The helicase activity of MCM 
unwinds the DNA paving the way for the recruitment of other factors such as Cdc45, 
RPA and DNA polymerases. 
 
2.1.2.2 Origin of DNA replication in Drosophila melanogaster 
The definition of an origin of replication in Drosophila melanogaster is more 
complicated as compared to Saccharomyces cerevisiae. It has been shown that in the 
Legend 
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early embryo stage of Drosophila melanogaster, initiation of replication is not 
localized to a specific site, as in Saccharomyces cerevisiae. Rather, initiation occurred 
on multiple sites within the same chromosome, and apparently with little or no regard 
for specific DNA sequences (Shinomiya and Ina, 1991). 
 
However, during the oogenesis stage of Drosophila melanogaster, DNA sequence 
specific replication initiation is employed for a special function: to produce sufficient 
levels of eggshell, otherwise known as the chorion. This gene amplification strategy 
employed by the organism serves as an interesting area of study into DNA replication 
in metazoans as it also employs similar replication proteins used in replicating the 
genomic DNA as Saccharomyces cerevisiae (Calvi and Spradling, 1999). The 
Drosophila origin recognition complex was identified as a homolog of the 
Saccharomyces ORC (Gossen et al., 1995) that could bind to specific DNA sequences, 
in this case the amplification control element on chromosome 3, ACE3 and 
amplification enhancing regions, AER-d (Austin et al., 1999). More detailed work 
identified an 884bp element, oriβ, which overlaps the AER-d as the major site of 
replication initiation. These two DNA sequences, necessary for gene amplification, 
were able to induce amplification when inserted into locations other than the 
chromosomes they were located on (Lu et al., 2001). Further mutational studies in 
oriβ showed that two important elements were required; a 140 base-pair sequence 
found in the 5’ region and a 226 base-pair AT rich sequence in the 3’ region that had 
significant homology to ACE3.  
 
Interestingly, despite the fact that both Drosophila and Saccharomyces ORC share 
homology, and that both oriβ and ARS contain AT rich sequences, Zhang and Tower, 
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2004, showed that the ARS was unable to replace the oriβ in directing amplification. 
In addition, in-vitro studies involving measuring the binding affinity of Drosophila 
ORC with origin and non-origin DNA indicated that the largest difference in binding 
affinity was only six-fold and it was proposed that this difference was not enough to 
differentiate between origin and non-origin DNA. On the other hand, the topological 
state of the DNA appeared to be more crucial, with negatively supercoiled DNA 
binding 30 fold higher to Drosophila ORC when compared to relaxed or linear DNA 
(Remus et al., 2004). This gives an indication that something else apart from AT rich 
sequences is needed for ORC binding. 
  
2.1.2.3 Origin of DNA replication in mammalian cells 
Similar to Drosophila, trying to identify distinct elements of DNA capable of 
initiating replication in mammalian cells is more complicated as compared to yeast. In 
1991, Heinzel et al. tried to isolate a human equivalent of the yeast ARS. However, 
instead of finding a distinct DNA element capable of initiating replication, they found 
that any piece of large human DNA sequence was sufficient for the autonomous 
replication in human cells. Since then, more work has been done in trying to identify 
and understand the mechanisms behind origins of replication in mammalian cells. 
However, despite the progress made in identifying these sites of replication initiation, 
a lot of work remains to be done in understanding how they work. Gilbert (2001), 
suggested that there exist two different types of origins: the first type being a zone of 
initiation, where replication can be initiated at multiple sites on a large fragment of 
roughly 10 to 50 kilo-base-pairs of DNA, while the other type include a more 
localized initiation site consisting of a few kilobase pairs.   
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An example of the first type of origin is the Chinese hamster ovary dihydrofolate 
reductase (DHFR) locus. It was early replicating and was found within a highly 
amplified region of the genome. In addition, this DHFR locus started incorporating 
nucleotides early in the S phase in three regions, an indication of replication 
(Milbrandt et al., 1981; Heintz and Hamlin, 1982). Further detailed work was done to 
show that replication initiation was preferably located to two specific loci termed oriβ 
and oriγ (Anachkova and Hamlin, 1989; Leu and Hamlin, 1989), and that oriβ could 
initiate replication in both hamster and human cells, even when placed in random 
locations out of its native state (Altman and Fanning, 2001 and 2004). However, it 
was also discovered that replication could start from multiple sites within the DHFR 
locus, although initiation was preferred for the 55kb intergenic region which 
contained the oriβ and oriγ (Dijkwel and Hamlin, 1995). On top of that, despite oriβ 
being the preferred choice of replication initiation, deletion studies done with oriβ had 
no effect on the replication initiation in the DHFR on a whole, indicating that the 
other origins could initiate replication efficiently even without oriβ (Kalejta et al., 
1998). Furthermore, the appearance of bubble arcs in almost every restriction 
fragment of the 55kb intergenic region tested using two-dimensional gel analysis and 
a PCR-based nascent strand abundance assay on restriction fragments that showed 
almost all the fragments tested positive for replication initiation corroborated the 
observation that the region responsible for replication actually contains multiple sites 
that have varying efficiencies of replication initiation (Dikjwel et al., 2002). 
 
An example of the second class of origin as suggested by Gilbert (2001) included the 
human lamin B2 gene. Lamins are intermediate filaments usually found in the nucleus 
providing support for the nuclear membrane. It was discovered by Giacca et al. (1994) 
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that the origin of replication for this gene was located at the 3’ end and was 
approximately 500 base-pairs long. Further methods aimed at investigating the 
proteins bound to the lamin B2 origin were done. UV irradiation using a pulsed laser 
light source, followed by immunoprecipitation showed that components required for 
pre-RC formation such as the Cdc6 and MCM proteins were present at the origin 
(Abdurashidova et al., 2004).  In addition, the lamin B2 origin was also shown to be 
able to initiate replication not only in ectopic locations of the chromosome but in 
hamsters as well (Altman and Fanning, 2004), providing evidence that one, the human 
lamin B2 origin is a true origin of replication and two, the human DNA replication 
system may share similar characteristics to other eukaryotic systems. Another 
replication origin that be classified under this second class of origin was found in the 
human β-globin gene. It was also shown that like the lamin B2 origin, the β-globin 
origin could enable replication at ectopic locations in the chromosome (Aladjem et al., 
1998). 
 
However, despite the success in identifying these origins of replication in mammalian 
cells, many questions still remain. Why are we still unable to identify other similar 
origins? Is there or is there not a consensus sequence that can be used to identify these 
origins as is the case in yeast ARS?  A recent work published by Vashee et al. (2003) 
showed that human ORC was able to restore DNA replication in Xenopus eggs 
depleted of Xenopus ORC. They also showed that the human ORC did not distinguish 
between origin and non-origin DNA and could bind to both forms. Not only could 
they bind to non-origin DNA, they also showed that the human ORC could initiate 
replication of plasmids containing origins and plasmids that did not have origins. 
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It would seem that although replication origins have been isolated from eukaryotic 
systems, specific DNA sequences do not appear to be a prerequisite for the binding of 
ORC to occur. In order to minimize any ambiguity, it was decided to use a more 
defined origin of replication for this study, the Epstein-Barr virus, EBV latent origin 
of replication oriP. 
 
2.2 Epstein Barr Virus 
In the beginning of 1940’s, a British missionary surgeon by the name of Denis Burkitt 
noted that lymphomas or lymphocyte tumors occurred at a frequent rate in equatorial 
Africa as compared to the rest of the world. The lymphomas, also known as Burkitt’s 
lymphoma, were also unique in that they were found outside of the lymph nodes. 
Burkitt then wrote and talked about this unique lymphoma widely, raising the 
possibility that the cause of this lymphoma could be by an infectious agent (Burkitt 
and Wright, 1966). After listening to Burkitt speak on his findings, Tony Epstein 
decided to obtain tumor biopsies and attempt to culture the lymphoma cells, which he 
was successful in achieving. In 1964, together with Achong and Barr, Epstein 
managed to identify a herpesvirus in electro micrographs of tumor cells (Epstein et 
al., 1965). In addition, they managed to show that this herpesvirus was different from 
other members of the family. This virus was unable to replicate in other cell cultures 
and was non-reactive to antibodies that react with other herpesvirus. It was 
subsequently called Epstein-Barr virus and became the first virus to play a possible 
role in causing tumors in humans. 
 
Now, EBV has been classified as a member of the gammaherpesvirus subfamily, 
which contains potentially tumorigenic herpesviruses (Chang et al., 1994). This 
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subfamily currently includes gamma 1, also known as LCV and gamma 2, also known 
as RDV, genera. Up to now, EBV is the only LCV known to affect humans and has 
been implicated as the etiological agent in causing, apart from Burkitt’s lymphoma, 
Hodgkin’s disease, some unusual T-cell lymphomas and nasopharyngeal carcinoma. 
(Klein, 1994; Karimi and Crawford, 1995; Kieff and Rickinson, 2001). 
 
2.2.1 Epstein Barr Virus latent origin of replication oriP 
In a latent infection with EBV, the 165kb viral genome exists as a piece of 
circularized extrachromosomal episome that can be maintained autonomously in the 
proliferating latently infected cells (Lindahl et al., 1976 and Nonoyama et al., 1972). 
It was discovered that a 1.7kb region of the viral genome, called oriP could mediate 
replication as well as nuclear retention of the viral episome in the cell. However, the 
oriP can only do so if a single EBV nuclear protein, EBNA-1 is present. Yates et al. 
(1984) have shown that recombinant plasmids containing the oriP could be 
maintained in the presence of EBNA-1, Replication can occur at most once per cell 
cycle (Yates and Guan, 1991) and the cell cycle machinery seems to be the 
controlling mechanism (Laskey and Madine, 1996). Reisman et al. (1985) have 
shown that oriP consists of two regions that do not touch one another: one being the 
dyad symmetry (DS) and the other being the family of repeats (FR). Although both 
contain EBNA-1 binding sites and require EBNA-1 to function, they are structurally 
distinct from one another and both serve different functions. 
 
Rawlins et al. (1985) have shown that the DS region consists of a 120bp region, 
which contains four EBNA-1 binding sites. Of which, two of the EBNA-1 binding 
sites are tandem while the other two are arranged in a dyad symmetry. The ultimate 
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role of the DS region is to initiate the replication of the DNA (Harrison et al., 1994). 
In fact, it has been shown by various groups that the human ORC is loaded onto the 
DS and they suggested that this is possible through interaction with EBNA-1 
(Chaudhuri et. al., 2001; Dhar et. al., 2001; Schepers et. al., 2001).  
 
The FR region is a family of repeats consisting of 21 imperfect repeats, each of 30 
basepairs in length; although only 20 of them contain EBNA-1 binding sites (Rawlins 
et. al., 1985). This region plays the role of mediating nuclear retention of the plasmid 
that involves the physical binding of EBNA-1 to the FR on the plasmid and the 
chromosomal DNA. This nuclear retention ability ensures that the plasmid is 
segregated and maintained in the nucleus during mitosis (Mackey et al., 1995; Yates 
et al., 2000). Reisman and Sugden (1986) have shown that upon binding to EBNA-1, 
the FR may also act as an enhancer for transcription. This transcriptional enhancer 
affects gene expression downstream of the FR. Wysokenski and Yates (1989) have 
also shown that this enhancer function required at least 6 to 7 copies of the 30bp 
repeats found in the FR. 
 
2.2.2 EBNA-1 protein 
Apart from the oriP, EBNA-1, a trans-acting EBV-encoded nuclear antigen, is 
essential for the long-term persistence and replication of EBV genome in infected 
cells during latent infection and of any plasmid bearing the oriP. As shown in figure 
3, EBNA-1 consists of 641 amino acids. Amino acids 33-83 and 328-382 are arginine 
rich domains. Amino acids 379-386 contain the nuclear localization signal. It was also 
recently shown that EBNA-1 can function as a transcriptional activator and that amino 
acids 65 to 89 were necessary to activate transcription (Kennedy and Sugden, 2003). 
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In addition, Ambinder et. al. (1991) as well as Chen et. al. (1993) have shown that the 
DNA binding and dimerization domain are found in amino acids 459-604 while 
Levitskaya et al. (1995) showed that amino acids 90-327 make up a domain of 
glycine-alanine repeats that render EBNA-1 resistant to degradation by protease and 
recognition by cytotoxic T cells. In addition, EBNA-1 was found to have induced B-
cell neoplasia in transgenic mice in one study (Wilson et al., 1996) but not another 
(Kang et al., 2005).  
 
2.2.2.1 Role of EBNA-1 in the persistence of any plasmids bearing oriP 
The N-terminus of EBNA-1 was shown to play a critical role in mediating binding of 
the episome to the chromosome (Hung et al, 2001). It was also found that this N-
terminus could be replaced by high-mobility group-I amino acids 1-90 or by histone 
H1-2 to mediate binding to the chromosome and mediate long-term persistence of the 
episome. The C-terminus of the EBNA-1 binds to the DNA sequences containing 
binding sites for EBNA-1, such as the DS and the FR element of the oriP (Kieff and 
Rickinson. 2001). This creates a physical association between the EBV and the host 




















Figure 3. Schematic representation of EBNA-1. EBNA-1 essentially consists of 
four main components. The orange lines indicate the chromosome-binding domains. 
These chromosome-binding domains lie in two regions amino acids 32-89 and 328-
386, both of which are rich in arginine residues. The nuclear localization signal is 
located from amino acids 379-386. Both the dimerization (purple) and DNA binding 
domain (blue) overlap each other within the C terminus. 
 
2.2.2.2 Use of Epstein-Barr Virus based gene therapy vector 
There are a few advantages of utilizing a gene therapy vector based on the Epstein-
Barr Virus. Being episomal, such vectors hold several advantages over other vectors 
such as those that employ integration. One advantage of episomal vectors over 
integrative ones is the fact that there is no need for the negative effects integration 
might bring about to both the therapeutic gene as well as cellular endogenous genes. 
Secondly, multiple copies of the episomal vectors can exist in the nucleus, which 
allow for amplified expression of the therapeutic gene.  
 
A standard vector derived from the Epstein Barr Virus contains the origin of 
replication oriP and the sequence encoding for the trans-acting factor EBNA-1. These 
two sequences are necessary for the retention as well as the replication of the EBV 
based vector. As seen in figure 4 below, EBV-based vectors can also be used as 
N C
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shuttle vectors by incorporating a bacterial origin of replication as well as a selection 
marker for bacteria like ampicillin resistance for easy amplification and manipulation 
within bacterial cells. However, it was discovered that vectors bearing the oriP of 
EBV could still undergo limited replication even without the presence of EBNA-1, 
although EBNA-1 is vital for the long-term persistence of plasmids bearing oriP 
(Aiyar et. al., 1998). EBV based vectors have been mainly used in primate cells, with 
reports of failure to replicate in mouse and hamster cells (Yates et. al., 1985; 
Wysokenski and Yates, 1989). This poses a setback for gene therapy applications as 
testing on mouse models would not be possible. However, even though murine 
models were not permissive for EBV, it was discovered that when murine cells were 
transfected with the EBV vector, the marker gene was expressed more intensively 
than a conventional vector (Tomiyasu et. al., 1998). This could be partially due to the 
transcriptional enhancer effect of the FR and the fault that the vector could not 

























Figure 4. A basic EBV based vector. It consists of the viral sequences oriP (white 
arrow) and ENBA-1 expression cassette (white arrow) as well as a eukaryote selection 
marker inclusive of promoter and polyA sequence (black arrows). A bacterial origin 
of replication (grey block) is also included for shuttling between prokaryotic and 
eukaryotic systems. An antibiotic resistance marker (grey arrow) is also provided for 
selection within bacteria. The EBV oriP consists of two noncontiguous repeats. The 
dyad symmetry (DS), which has 4 EBNA-1 binding sites denoted by the blue lines 
and the family of twenty 30bp repeats (FR) which has 20 EBNA-1 binding sites, also 
denoted by blue lines.  
 
Most of the developments for an efficient episomal vector for gene therapy have come 
from EBV based vectors, where transient yet high levels of expression of the 
therapeutic gene is required as in the case of Duchenne Muscular Dystrophy. 
Research has already shown that intramuscular injection of the EBV based dystrophin 
expression vector into murine models resulted in a significant enhancement of the 
expression of the dystrophin as compared to conventional vectors (Tsukamoto et. al., 
1999). In addition, the persistence of EBV vectors in humans had been found to be 
prolonged but not indefinite. This is particularly useful when the goal is to kill off the 
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human B-lymphomas where the gene was shown to be stably expressed over a period 
of a few weeks (Mücke et. al., 1997; Robertson et. al., 1996).  
 
The major disadvantage of using EBV based episomal vectors is that it requires the 
expression of the trans-acting viral factor EBNA-1 for stable maintenance. While 
previous work done by Lutfalla et. al. (1989) show that plasmids bearing the EBV 
oriP were able to replicate stably in hepatic cells overexpressing EBNA-1 without 
interference to the expression of liver-specific proteins, other experiments have  
showed  that EBNA-1 could  bind to RNA  in  vitro  which  meant that EBNA-1 was 
capable of influencing expression of a gene post-transcriptionally (Snudden et. al., 
1994). In addition to that, EBNA-1 may induce B-cell lymphoma in transgenic mice 
(Wilson et. al., 1996), thus raising safety concerns regarding the use of this vector for 
gene therapy. 
 
A possible way to circumvent these potential problems associated with EBV based 
vectors would be to find a way to regulate the expression of EBNA-1 or the physical 
replication of the vector. 
 
2.3 Transcription 
Transcription is another major process in cells which allows the cell to produce the 
necessary proteins that are vital for survival. Just like DNA replication, the inability 
of a cell to undergo transcription often results in fatal consequences. And similar to 
replication, it mainly involved three main stages: initiation, elongation and 
termination. This section will deal on the different systems of transcription in 
prokaryotes and eukaryotes before discussing the possible interplay that could exist 
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between these two processes.  
 
2.3.1 Prokaryotic transcription 
In prokaryotes, transcription is performed by one form of RNA polymerase. The 
prokaryotic RNA polymerase holenzyme is a multisubunit protein complex consisting 
of a core enzyme made up of 2 α subunits, 2 β subunits and 1 ω subunit (Zhang et al., 
1999) and an additional σ factor, which enables the holoenzyme to recognize specific 
binding sites at the -10 and -35 of the promoter (Dombroski et al., 1992).  
 
When the RNA polymerase holoenzyme binds to the promoter, the double stranded 
DNA is separated into single strands to form a transcription bubble. As the 
polymerase starts incorporating nucleotides from the +1 site, there exists a chance that 
abortive initiation, in which transcription is aborted, may occur in the first 17 
nucleotides synthesized (Ring et al., 1996). When that happens, the RNA polymerase 
releases the transcript and will start synthesizing a new strand of RNA from the first 
base.  
 
As the RNA polymerase progresses from initiation to elongation, the σ factor is no 
longer needed and is generally thought to be released from the core enzyme 
(Shimamoto et al., 1986), although there has been a recent report of a population of 
RNA polymerases that retain the σ factor through the transition from initiation to 
elongation (Bar-Nuham and Nudler, 2001). The Escherichia coli elongation factor 
NusA was shown, upon σ factor release, to be capable of interacting with the 
elongation complex, comprising of the core enzyme, DNA template and the growing 
RNA transcript, and inducing termination. Upon termination of transcription, the 
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NusA protein dissociates from the RNA polymerase core enzyme and allows the σ to 
bind again, thereby allowing transcription to be initiated again (Greenblatt and Li, 
1981; Schmidt and Chamberlin, 1984; Gill et al., 1991).  
 
During the transcription elongation stage, certain scenarios may occur that may 
impede the elongation complex. Transcriptional pausing was first discovered in-vitro 
using the Escherichia coli RNA polymerase. Despite synchronously initiating 
transcription, varying lengths of RNA transcripts resulted, demonstrating that 
elongation was not synchronous. It was attributed to specific pausing sites on the 
DNA template (Kassavetis and Chamberlin, 1981) and can be suppressed by the 
presence of transcription factors such as NusG (Burova et al., 1995). Transcriptional 
arrest on the other hand is more severe than pausing in that arrested elongation 
complex is unable to resume transcript elongation without the addition of accessory 
factors (Arndt and Chamberlin, 1990). In transcriptional arrest induced by limiting 
substrate nucleoside triphosphates (NTPs), the RNA polymerase, although active, was 
unable to proceed with elongation and can be re-activated upon the provision of the 
missing NTPs. However, for some templates elongation could not be restored 
demonstrating the potential irreversible effect of transcriptional arrest. Indeed, 
Komissarova and Kashlev (1997) demonstrated that during transcriptional arrest in 
Escherichia coli, the RNA polymerase could actually disengage from the growing 
transcript and translocate backward, resulting in the extrusion of the 3’ end of the 
RNA.  
 
2.3.2 Eukaryotic transcription 
One of the most well studied eukaryotic transcription systems comes from yeast. 
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More complex than the prokaryotic system, the eukaryotic transcription consists of 
three types as compared of one type RNA polymerase in prokaryotic system. RNA 
polymerase I synthesizes ribosomal RNA, RNA polymerase II synthesizes messenger 
RNA and RNA polymerase III synthesizes tRNAs and other small RNAs. Although 
they serve to create different forms of RNA, the subunits of all three polymerases are 
either identical or homologous (Woychik et al., 1993; Sentenac, 1985). This section 
shall discuss briefly on some of the basic characteristics of RNA polymerase II 
initiation and elongation. 
 
 
2.3.2.1 RNA polymerase II 
The RNA polymerase core enzyme is made up of 12 subunits, termed Rpb, 1-12. 
Crystal structure studies of these 12 subunits have revealed a 10 subunit catalytically 
active core and a separate 2 subunit heterodimer consisting of Rpb4 and Rpb7 
(Armache et al., 2003; Bushnell and Kornberg, 2003). One of the suggested functions 
of this heterodimer could be to assist the polymerase in interacting with a variety of 
transcription factors (Armache et al., 2003). 
 
Apart from the RNA polymerase, two other components are required for transcription. 
One of the two components is a 20 subunit protein complex called the Mediator which, 
like its name suggests, acts as a mediator for transducing signals from transcriptional 
activators or repressors (Kelleher et al., 1990; Kim et al., 1994; Gustafsson et al., 
1998). The other component needed include a set of five additional transcription 
factors TFIIB, D, E, F and H. TFIID is also a complex made up of a universal TATA-
binding protein (TBP) and additional TBP-associated factors (TAFs) (Conaway and 
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Conaway, 1997; Lee and Young, 1998). Before transcription initiation, the TFIID 
binds to the promoter region and recruits the mediator complex and the RNA 
polymerase II as well as other transcriptional factors to form the preinitiation complex. 
But given that DNA is wrapped around histones in its native state as a nucleosome, 
how then does the transcription activators and holoenzyme gain access to the 
sequences to activate transcription? To do that, the nucleosome would have to be 
remodeled such that the DNA elements are free to interact with the transcription 
activators and holoenzymes. The SWI (homothallic switching deficient) / SNF 
(sucrose non-fermenting) protein complex was one such complex capable of 
remodeling the nucleosome (Brown et al., 1996). In the presence of a transcriptional 
transactivator, such as the human heat shock factor 1 (HSF1), SWI/SNF was recruited 
to the chromatin, where it may remodel the nucleosome in an ATP dependent manner, 
and this could possibly result in the opening of the nucleosome, thereby enabling the 
entry of the transcriptional machinery.   
 
Following the formation of the preinitiation complex, local unwinding of the DNA 
template occurs resulting in an open complex. This process is dependent on ATP as 
well as on the transcription factors TFIIE and TFIIH (Holstege et al., 1996; Kim et al., 
2000). Preinitiation then proceeds to initiation, a process marked by the addition of 
nucleoside triphosphates. Initiation can only move on to elongation after the promoter 
has been cleared by the RNA polymerase. This early stage of transcription, also 
known as promoter clearance, is marked by the tendency of the RNA polymerase to 
slip during the synthesis of the first 23 nucleotides, after which no slippage is 
detectable (Pal and Luse, 2003), which is not too different from the prokaryotic 
system of abortive initiation. It was also shown that the RNA polymerase II transcript 
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elongation complex (TEC) is unstable before the growing RNA transcript-DNA 
template hybrid reaches 8 nucleotides in length (Kireeva et al., 2000). Certain general 
transcription factors such as TFIIF and TFIIH have been shown to be capable of 
suppressing the occurrence of abortive initiation during promoter clearance (Dvir et 
al., 1997; Yan et al., 1999). 
 
Similar to the prokaryotic system, transcriptional pausing or arrest may also occur 
during the elongation stage in eukaryotes. One of the first descriptions of 
transcriptional arrest in eukaryotes came from work on the histone3.3 gene and it was 
shown that arrest could occur in both the coding and non-coding region. It was also 
shown that this arrest can be alleviated by the presence of elongation factor TFIIS 
(Reinberg and Roeder, 1987; Reines et al., 1989). Further examination of one of the 
strongest arrest sites in the histone 3.3 gene revealed that it contained a T-rich region 
for the non-template strand. It was suggested that the structure of the template could 
play a role in arrest as such T-rich regions could contain a bend in the DNA double 
helix (Kerppola and Kane, 1990). TFIIS was found to be able to reactivate arrested 
polymerase by inducing endonucleolytic cleavage of the nascent transcript near the 3’ 
end, resulting in the creation of a new 3’-OH terminus that is correctly based paired to 
the DNA template, thus allowing elongation to carry on (Reines, 1992; Reines et al., 
1992; Izban and Luse, 1992). Apart from TFIIS, there are many other elongation 
factors such as ELL, TFIIF and Elongin that can interact directly with the polymerase 
during elongation. However, there exists a second class of elongation factors that 
while they do not affect the polymerase activity directly, they may affect the 
progression of elongation through the modification of chromatin. The two main 
proteins identified so far include the Elongator and FACT. Elongator was first 
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identified as a six protein subunit complex (Otero et al., 1999; Winkler et al., 2001) 
that possessed histone acetyltransferase on one of its subunits Elp3 and could 
acetylate core and nucleosomal histones (Kim et al., 2001) and therefore could 
possible facilitate elongation. FACT was shown to be able to facilitate RNA 
polymerase II elongation on chromatin templates in-vitro. It was proposed that FACT 
could promote RNA polymerase II elongation through nucleosomes by binding to and 
promoting the removal of histones, such as H2A and H2B (Orphanides et al., 1999). 
 
2.4 Relationship between DNA replication and transcription 
This section examines some of the already existing relationships between DNA 
replication and transcription and talks about some of the evidence supporting each 
claim.  
 
2.4.1 Transcription through an origin of replication may inhibit DNA replication 
DNA replication and transcription occur throughout the cell cycle in bacteria 
simultaneously. As they utilize the same DNA template for their purposes, it would 
seem inevitable that both the replication and transcription machinery would meet one 
another along the way either traveling in the same direction or head on. And it would 
seem that collisions between the two would also be unavoidable, given that 
replication and transcription are both polar. Such a phenomenon was first observed in 
Escherichia coli by French (1992). An inducible origin of replication was placed on 
either side of a ribosomal RNA operon. It was observed that replication and 
transcription occurring in opposite directions resulted in a slower replication fork 
progression. This could be either due to physical collision between the polymerases or 
it could be due to topological factors. As transcription and replication proceeds, they 
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generate positive supercoiling in downstream DNA (Liu and Wang, 1987; Peter et al., 
1998). As they meet head on, the positive supercoil generated by the two could have a 
negative effect on both. Further work by Mirkin and Mirkin (2005) confirmed the 
observation that replication was inhibited as it met transcription head on. In addition 
to the possibility that the positive supercoils generated could have inhibited 
replication, the authors also suggested that the physical collision between the two 
machineries could also play a part. At the same time the authors also found that 
replication elongation traveling in the same direction as transcription did not seem to 
affect one another. They proposed that in this case, the DNA replication machinery 
either bypassed or displaced the RNA polymerase from the DNA template as they 
traveled co-directionally. 
 
When a yeast origin of replication ARS was placed under the effect of an actin 
promoter, replicative ability was affected negatively (Kipling and Kearsey, 1989; 
Tanaka et al., 1994). It was shown using micrococcal nuclease assay and indirect end-
labeling that chromatin structures were not affected and so chromatin remodeling due 
to the positioning of the ARS near a promoter was ruled out and it was concluded that 
transcription through the origin of replication altered the activity of the ARS. In 
addition, transcription into the ARS resulted in an increase in dependence of the 
MCM complex, an indication that there exists a negative relationship between pre-RC 
assembly and transcription (Nieduszymski et al., 2005). Interestingly, MCM1, which 
is needed for the initiation of replication in yeast (Chang et al., 2004), can also act as 
a transcriptional co-repressor of MATα2 (Keleher et al., 1989).  
 
In Tetrahymena thermophila, transcription through the origin of replication rDNA by 
 
Survey of Literature 
 32
placing the origin immediately downstream of a RNA polymerase I promoter resulted 
in the failure to replicate. Replication could be restored by placing an rRNA 
transcriptional terminator between the promoter and the origin, or by inducing a 
mutation to inactivate the promoter, and the authors proposed that transcription 
through the origin could inhibit replication initiation (Pan et al., 1995). 
 
In 1991, Heinzel et al. found that any piece of human DNA that was large enough 
could support autonomous replication of the plasmid it was found on. Using that 
knowledge, Haase et al. (1994) tried to study the effect transcription had on such 
replicating plasmids. They found out that the ability of plasmids to replicate was 
inversely correlated to the promoter strength and that similar to what was observed in 
Tetrahymena thermophila, the insertion of a transcription termination sequence 
downstream of the promoter restored the ability to replicate. The authors also 
proposed that transcription could inhibit replication by preventing replication 
initiation.  
 
2.4.2 Transcription factors may affect DNA replication positively 
While there has not been much evidence showing that the transcription machinery 
through an origin could affect replication in a positive way, there have been quite a lot 
of studies that cast transcription factors playing a positive role in affecting replication. 
This section will deal on some of the studies done so far.  
 
In the yeast ARS1, a binding site for transcription factor Abf1 exists in the B3 
element. The binding of this transcriptional factor had a positive effect on replication 
and this ability to activate replication was mapped to the C-terminal acidic domain of 
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the Abf1. In addition, it was discovered that Abf1 could also be replaced by other 
transcription factors from different organisms such as VP16 from the herpes simplex 
virus or the p53 tumor suppressor protein from humans, suggesting that conserved 
mechanisms that could exist between organisms in using transcriptional factors for the 
activation of replication (Li et al., 1998). However, there has been evidence to the 
contrary. ARS301 is an inactive origin in the chromosome but active when placed on 
a plasmid. But when the Abf1 transcription factor binding site was introduced near the 
ARS301, the origin was inactivated (Kohzaki et al., 1999). 
 
The Drosophila chorion gene amplification system as described in section 2.1.2.2 is 
one of the most well studied origins in multicellular eukaryotic organisms. As 
mentioned above, two elements within the origin are vital for replication: the ACE3 
and the oriβ. Interestingly, binding sites for Myb, a transcription factor, could be 
found within the region and was shown to be needed for replication. It was also 
shown that Myb could interact with ORC subunits and mutations in Myb resulted in 
reduced or no replication (Beall et al., 2002), providing evidence that transcription 
factors could affect replication in a positive way. In another study, microarray 
analysis was used on the Drosophila genome in a bid to identify replication origins 
and determine replication timing. It was shown that the ORC localizes to specific 
regions on the chromosome, many of which actually contain early-activating origins. 
In addition, these early activating origins contain RNA polymerase II binding sites as 
well, leading the authors to suggest that transcription activity could have a positive 
effect on origin activation (MacAlpine et al., 2004). 
 
Experiments utilizing human genome microarrays have yielded similar results. By 
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separating DNA from cells in S phase and DNA from cells in the G1 phase, the 
authors were able to compare the difference in DNA copy number using genomic 
array hybridization. They found that there was a positive correlation between 
replication timing and GC content, gene density as well as transcriptional activity 
(Woodfine et al., 2004). The fact that origins of replication were found near gene loci, 
such as the lamin B2 gene and the β-globin gene is a strong indication that 
transcription could have a positive effect on replication rather than a negative one. 
Further proof came from work done on the origin found in the β-globin gene locus in 
which a locus control region (LCR) that contained binding sites for transcription 
factors was found to be vital for replication initiation (Aladjem et al., 1995).  
 
A clue of how transcription factor may activate replication comes from Hu et al., 
(1999). In that study, the authors fused the transcriptional activator BRCA1 (breast 
cancer protein 1) to the DNA binding domain of the GAL4. Using this construct they 
showed that the GAL4-BRCA-1 resulted in a significant increase of plasmid stability. 
In addition, they showed that the presence of BRCA1 could remodel the chromatin. 
They proposed that one way in which transcription factors may affect replication 
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3.1 Polymerase Chain Reaction (PCR) amplification of EBV latent origin of 
replication oriP 
PCR was used to amplify the EBV latent origin of replication oriP. Primers were 
designed using the DNA sequence analysis software VectorNTI (InforMax. Inc. 
Maryland, USA). They were also analysed by the same software for any primer dimer 
formations that may potentially disrupt the PCR reaction. And they were synthesized 
by MWG-Biotech AG (Germany). The forward primer was designed in such a way 
that an Aat II restriction enzyme site was incorporated at its 5’ end while the reverse 
primer was designed with an Eco RI restriction enzyme site at its 3’ end. The 




3.1.1 PCR reaction setup 
Hotstartaq DNA polymerase (Qiagen) was used for PCR. This polymerase used was 
unique in that it was totally inactive at room temperature and required a pre-PCR 
cycle step of heating at 95°C for 15 minutes for the enzyme to be activated. This pre-
PCR cycle heating step was useful in ensuring target specificity and the yield of the 
PCR product. In addition, any primer dimers that could have resulted from 
complementary base pairing between the added primers would also be separated and 
extension of the primers was prevented. The 10 mM dNTP solution was supplied by 
New England Biolabs. A final PCR reaction volume of 100 µl for amplifying the oriP 
fragment was performed to obtain sufficient amount of PCR product for cloning. The 
reaction mix for the PCR reaction is shown in table 1. B95-8 whole cell DNA (250 
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ng), purified according to section 3.4.2 was used as the template and the PCR reaction 
was carried out using a thermal cycler (Applied Biosystems GeneAmp PCR System 
2400) with the parameters as shown in table 2. A total of 35 PCR cycles were run 
with an initial step of pre-PCR cycle heating at 95°C and a final holding step of 4°C. 
Cycle steps are indicated in bold.  
 
Reagents Final concentration  
Template DNA Specified in text 
PCR Buffer 1X 
Forward primer (100µM) 0.8 µM 
Reverse primer (100µM) 0.8 µM 
dATP, dCTP, dGTP, dTTP 500 µM each 
Polymerase 0.025 u/µl 
H2O q.s as specified in text 
Table 1. PCR reaction mix for amplifying oriP 
 
 
Step Temperature Time 
Hold 95°C 15 minutes 
Denaturation 94°C 45 seconds 
Annealing Specified in text 45 seconds 
Extension 72°C 1 minute 
Final extension 72°C 10 minutes 
Hold 4°C ∞ 
Table 2. PCR reaction conditions. 
 
3.1.2 Gel purification of PCR products 
After amplification by PCR, the products were run on a 0.8 % agarose gel (appendix) 
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and the DNA band that had the closest fragment size to the expected size of oriP was 
purified using Qiagen Gel purification Kit (Qiagen) and eluted using 50 µl of 10 mM 
Tris pH8.0 solution. After gel purification, the amount of PCR end product was 
estimated by measuring the absorbance of the PCR product at 260 nm using a 
spectrophotometer. 
 
3.1.3 Non-gel based purification of enzyme reactions 
Alternatively, instead of using gel purification, an easier way would be to utilize the 
Qiagen QiaQuick PCR purification kit (Qiagen) where the product does not need to 
be run on ethidium bromide containing agarose gel, thereby reducing any 
contamination with agarose or ethidium that may interfere with downstream steps.  
 
3.2 Restriction enzyme digestion  
Restriction enzyme digestion is a vital step in the cloning done throughout this entire 
study. All the restriction enzymes utilized in this study are from New England Biolabs 
and the buffers used are as recommended by the manufacturer. To achieve as 
complete a digestion by the enzymes as possible, the maximum units of enzymes are 
usually added, except for the reactions involving known enzymes with known non-
specific activity when used at high concentrations. In those cases, only 1 unit of 
enzyme per µg of plasmid was applied. Reaction conditions were usually at 37ºC for 
at least 5 hours to ensure complete digestion. 
 
For double restriction enzyme digests, certain enzymes share buffers which they are 
both active in. In cases where neither enzymes share a common buffer, sequential 
restriction enzyme digestion was conducted. The plasmid would first be digested with 
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one enzyme and then the buffer would be changed to an appropriate one using the 
Qiagen QiaQuick PCR purification procedure (section 3.1.3) before digestion with the 
second enzyme.  
 
The tables of all the restriction enzyme reactions can be found in appendix. 
 
3.3 Filling in of 5’ overhang and removal of 3’ overhang of restriction-digested 
plasmid DNA 
Filling in of 5’ overhangs and removal of 3’ overhangs was carried out using the T4 
DNA polymerase. The purified digested plasmid DNA (50 µl) was mixed together 
with the polymerase, BSA and dNTPs as shown in table 3 to a final reaction volume 
of 60 µl. The reaction was incubated at 12ºC for 1 hour before heat inactivating the 
enzyme by treating the reaction at 75ºC for 10 minutes. 
 
Reagent Final concentration 
DNA sample Specified in text 
BSA(10mg/ml) 50 µg/ml 
10mM dNTP 100 µM 
10X T4 polymerase buffer 1X 
T4 polymerase 0.1 u/µl 
H2O q.s as specified in text 
Table 3. T4 DNA polymerase reaction mix 
 
3.4 Ligation of the insert and plasmid vector DNA 
Ligation was another vital reaction used in the cloning steps. The insert DNA was 
ligated to the plasmid vector DNA using T4 ligase (New England Biolabs). The 
proportion of vector to insert was kept at a 1:3 molar ratio. The reaction was set up as 
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described in table 4 below and incubated at 16ºC overnight using a thermal cycler. 
 
Reagent Final concentration 
Vector Specified in text 
Insert Specified in text 
Ligase 40 c.e.u/µl 
10X Ligase buffer 1X 
H2O q.s as specified in text 
Table 4. Ligation reaction mix c.e.u= cohesive end units 
 
3.5 Manipulation of Escherichia coli DH10B strain  
 
3.5.1 Preparation of electrocompetent DH10B cells 
A single colony from a streak plate of DH10B was picked and used to inoculate 100 
ml of LB broth. This starter culture was incubated at 37ºC with shaking at 200 rpm 
overnight in a shaker. (Innova 4300 incubator shaker by New Brunswick Scientific) 
The overnight starter culture was then used to further inoculate 1 L of LB broth. The 1 
L of culture was then placed into a shaker and incubated at 37ºC with shaking at 200 
rpm. O.D readings at 600 nm were taken every 30 minutes and incubation terminated 
when a suitable O.D reading of about 0.5A to 0.7A was observed. The cells were 
incubated on ice for 15-30 minutes before being centrifuged at 1500 g (Kubota 2000) 
for 15 minutes at 4ºC. After centrifugation, the supernatant was carefully decanted 
away and the cell pellet re-suspended in 1 L of sterile 10 % ice-cold glycerol. After 
re-suspension, the cells were centrifuged again at 1500 g for 15 minutes at 4ºC. The 
supernatant was again carefully discarded after centrifugation and the cells re-
suspended in 20 ml of sterile 10 % ice-cold glycerol. The re-suspended cells were 
centrifuged one last time at 1500 g for 15 minutes at 4ºC and finally re-suspended in 2 
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ml of sterile 10 % ice-cold glycerol. 50 µl aliquots were dispensed into sterile 1.5 ml 
micro-centrifuge tubes for a single use tube of electro-competent DH10B cells and 
kept at a -80ºC freezer for long term storage. 
 
3.5.2 Electro-transformation of electrocompetent DH10B cells 
1 ng of supercoiled pcDNA3.1+ plasmid vector (Invitrogen) was used to test the 
efficiency of the electro-competent DH10B cells. The plasmid was first diluted to a 
concentration of 1 ng/µl using 10 mM Tris, pH 8.0. One tube of electro-competent 
cells was then allowed to thaw on ice before adding 1 µl of plasmid solution. This was 
mixed well by gently pipetting the cell suspension up and down. The cells were 
dispensed into a pre-chilled 1 mm cuvette (BioRad) and electro-transformed at 1800 
V, 25 µF, 200 Ω in an electro-porater (BioRad). 450 µl of SOC broth was added 
immediately after electro-transformation and the reconstituted cells were left at 37ºC 
for 1 hour with shaking. The cells were plated onto LB agar plates containing 50 
µg/ml of ampicillin and incubated overnight at 37ºC.  
 
 
3.5.3 Preparation of small amount of plasmid  
Individual colonies that grew overnight on the LB + ampicillin agar plate were picked 
using   a   sterile   pipette tip.  Each   colony was suspended in 3 ml of LB broth with 
50 µg/ml of ampicillin (appendix). 10 µl of the resuspended bacteria was streaked on 
a fresh LB + ampicillin agar plate using a sterile loop to obtain a purity plate of the 
transformants. The LB + ampicillin broth inoculated with individual colonies were 
then incubated at 37°C overnight with shaking at 220 rpm until a confluent bacterial 
culture was obtained as a preliminary culture for plasmid analysis. The bacterial cells 
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were harvested from this culture by centrifuging at 1500 g using a centrifuge 
(Beckman) for 10 minutes and the plasmid extracted using Qiagen plasmid miniprep 
kit (Qiagen).  
 
3.5.4 Preparation of higher amount of plasmid  
Upon confirming the identity of the plasmid, a larger amount of the plasmid was 
obtained. A single colony was picked from the purity plate to inoculate 150 ml of LB 
broth + 50 µg/ml ampicillin and incubated at 37°C with shaking at 220 rpm overnight. 
800 µl of the overnight culture was mixed with 70 µl of DMSO and frozen at -80°C 
for long-term storage. The remaining culture was harvested by centrifugation at 1500 
g for 15 minutes and the plasmid was extracted using HiSpeed Plasmid Maxi Kit 
(Qiagen) to obtain a final yield of approximately 1 mg of plasmid DNA. Further 
analysis using the appropriate restriction enzymes (section 3.2) was conducted on the 
plasmid isolated. The plasmid was then placed in a refrigerator at -20°C for storage. 
 
 
3.6 Maintenance and manipulation of B95-8 or BJAB cell line  
The B95-8 cell line was grown in 20 ml of R10 media (appendix) incubated at 37°C 
with 5 % CO2 and passaged every time the culture reached a cell density of 106 
cells/ml. No trypsin was added, as both B95-8 and BJAB are suspension cell lines 
although B95-8 does exhibit weak adherent characteristics. By using a sterile pipette, 
R10 media was used to wash any cells that remained adhered to the culture flask even 
after gentle shaking and the re-suspended cells were diluted twenty-fold using fresh 
R10 buffer to a final cell density of approximately 2 X 105 cells/ml. 
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3.6.1 Cell count using a hemocytometer 
Cells were well suspended by pipetting the culture up and down several times using a 
sterile pipette. 50 µl of suspended cells were diluted 2 X by mixing with 50 µl of 
trypan blue and the mixture was loaded onto a hemocytometer counting chamber 
(American Optics) and viewed under a phase contrast light microscope (Olympus 
IX51). Cells found within the four large squares at each of the corners of the counting 
chamber were counted and a pacer was used to help keep track of the count of viable 
cells, which appeared as bright spots under the microscope field. The cell density of 
the culture was calculated as follows: 
 
      Total cell count in large squares in 
counting chamber 
X 2 X 104 = cell density of cell culture (cells/ml)
4 
      
 
 
3.6.2 Extraction of genomic DNA from B95-8 
A total of 180 ml of B95-8 culture was grown to confluence. Upon reaching confluent 
growth, the cells were harvested first by using a sterile pipette to re-suspend all cells. 
The re-suspended cells were collected in 50 ml sterile propylene tubes and centrifuged 
at 300 g for 10 minutes. The genomic DNA from the resulting cell pellet was 
extracted from the harvested cells using the Qiagen Genomic DNA kit. 500 µg of 
genomic DNA obtained from B95-8 cell line was dissolved in sterile TE buffer to a 
final concentration of 0.5 µg/µl. 1 µl of the final DNA prep was taken for analysis 
with gel electrophoresis using a 0.4 % agarose gel in TAE buffer (appendix) with an 
applied voltage of 50 V for 3 hours. 
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3.6.3 Transfection of B lymphocyte cell lines B95-8 and BJAB 
The B95-8 cell line was chosen as the cell line to be transfected because it actively 
expresses the viral protein EBNA-1 and can be transfected more efficiently than other 
EBV positive cell lines. B95-8 is also a permissive cell line that results in a small 
number of cells entering the lytic cycle. BJAB was chosen as it did not express any 
form of viral antigen like EBNA-1 and would not support the replication of oriP 
containing plasmids. For both cell lines, cells were grown until mid-log phase, which 
has an approximate cell density of 0.5 X 106 cells/ml, before being harvested for 
transfection by electroporation. 20 ml or 107 of these mid-log phase cells were used 
for each transfection cuvette. The 20 ml cells were pipetted into sterile 50 ml 
propylene tubes and harvested by centrifugation at 300 g for 6 minutes. 400 µl of R10 
media was used to resuspend the cell pellet before transferring to the cuvette. The 
volume of DNA added, regardless of the concentration of DNA did not exceed 20 µl 
as the buffer in which the DNA was dissolved could affect the overall salt 
concentration in the cuvette and resulted in a less efficient transfection. 
Electroporation of the cells was done using BioRad GenePulser II with a selected 
voltage and the capacitance set at 950 µF. After electroporation, the cells were quickly 
re-constituted in 20 ml of fresh R10 media and incubated at 37ºC with 5% CO2. 
 
3.6.3.1 Optimization of transfection efficiency 
In the optimization of the transfection parameters, a GFP expressing plasmid pTracer 
(Invitrogen) was transfected into B95-8 and BJAB cells using different electroporator 
voltage settings. The transfected cells were incubated for 1 day at 37°C with 5% CO2. 
1.5 ml of the recovered cells was collected in a 1.5 ml microcentrifuge tube and 
harvested by centrifuging at 1800 rpm for 6 minutes. The supernatant was removed 
 
Materials and Methods 
 44
and the cell pellet was re-suspended in 50 µl of non-sterile 1 X PBS. 1 ml of the re-
suspended cells was placed onto an immunofluorescence slide and viewed under an 
immunofluoroscence microscope. The voltage with which the transfected cells 
exhibited the most intense fluorescence with the least amount of cell death was 
determined to be the most optimal voltage for transfection. 
 
3.7 Southern and Northern blot analysis  
50 µg of plasmid DNA was transfected into B95-8 and BJAB cells and the plasmids 
rescued after 72 hours and analyzed by southern blot to determine the proportion of 
plasmid that could replicate.  
 
 
3.7.1 Transfection of B95-8 and BJAB cells 
Transfection of B95-8 and BJAB cells was carried out as described in section 3.6.3 
using 50 µg of plasmid. The parameters used to transfect B95-8 and BJAB cells were 
250 V, 950 µF. After electroporation, the cells were quickly re-constituted in 20 ml of 
fresh R10 media and incubated at 37 ºC with 5 % CO2 for 72 hours. 
 
3.7.2 Isolation of whole cell RNA and DNA from transfected samples 
After 72 hours, the transfected cells were harvested by centrifuging at 1800 rpm for 5 
minutes. The supernatant was carefully removed without disturbing the cell pellet by 
using a sterile filtered pipette tip. Whole cell RNA and DNA were then extracted 
using the RNA and DNA isolation kit (Qiagen). As RNA is sensitive to RNase, gloves 
were worn throughout the entire procedure and all apparatus were cleaned with RNase 
AWAY (Amersham). The RNA obtained was redissolved in 5 µl of RNase free water 
 
Materials and Methods 
 45
and then quantified by measuring the absorbance at 260 nm. An additional step of 
treating the RNA with RNase free DNase I (Qiagen) was necessary to remove any 
contaminating DNA. The DNase I reaction was set up as described in table 5 below to 
a final reaction volume of 6 µl and incubated at 37 ºC for 1 hour. The treated RNA 
was then stored at -20ºC and saved for further Northern Blot analysis. The whole cell 
DNA isolated from the kit was re-suspended in 18 µl of 10 mM Tris.Cl, pH 8.0 and 
further digested with both Dpn I and another suitable restriction enzyme (to linearize 
the plasmid) in a double enzyme digestion reaction.  
 
Reagent Final concentration 
RNA Specified in text 
10X NEBuffer 2 1X 
RNase free DNase I 0.3 µl 
Table 5. RNase free DNase I digestion mix 
 
3.7.3 Preparation of labeled probes 
Three types of labeled probes were made using the neomycin phosphotransferase 
gene fragment from pcDNA3.1+, the EBV latent origin of replication oriP DNA and 
GAPDH cDNA. The neomycin resistance gene fragment was excised from 10 µg of 
pcDNA3.1+ plasmid DNA using the restriction enzymes Stu I and Sal I. The reaction 
was set up as described (appendix) to a final volume of 50 µl and incubated at 37 ºC 
for 5 hours. The neomycin resistance gene fragment was purified using gel extraction 
as described in section 3.1.2. OriP DNA was obtained as described in section 4.1.1.3 
using Sac II and Eco RI (appendix). GAPDH cDNA was obtained by first performing 
reverse transcription on total RNA and then amplifying out the product using 2 sets of 
primers as described below. 
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3.7.3.1 Reverse transcription-PCR 
Firstly, total RNA was isolated from BJAB cells as described in section 3.7.2. RT-
PCR was carried out using QIAGEN One-step RT-PCR kit (Qiagen). The reaction 
was set up as suggested by the manufacturer and can be seen in table 6 below to a 
final volume of 50 µl. The thermal parameters used were also suggested by the 
manufacturer and can be seen in table 7 below. A total of 35 cycles were run. The RT-
PCR products were analysed using agarose gel electrophoresis. 
 
Reagent Final concentration 
5X Qiagen One step RT-PCR buffer 1 X 
10 mM dNTPs 400 µM 
Forward primer 0.6 µM 
Reverse primer 0.6 µM 
Qiagen One step RT-PCR enzyme mix 0.2 u/µl 
RNA template 30 ng/µl 
RNase free water q.s as specified in text 
Table 6. RT-PCR reaction mix 
 
Table 7. One Step RT-PCR thermal cycling conditions 
 
Step Temperature Time 
Reverse transcription 50 ºC 30 minutes 
Initial PCR activation step 95 °C 15 minutes 
Denaturation 94 °C 45 seconds 
Annealing 55 ºC 45 seconds 
Extension 72 °C 1 minute 
Final extension 72 °C 10 minutes 
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3.7.3.2 Purification of cDNA products 
Purification of GAPDH cDNA products was performed as described in section 3.1.2 
using gel purification. The eluate was stored at -20ºC before downstream reactions. 
 
 
3.7.3.3 Labeling reaction 
The creation of labeled probes was done using the Gene Images Random Prime 
Labelling Module (Amersham Biosciences). The template DNA was first diluted to 
25 ng/µl using 10 mM Tris.Cl, pH 8.0 to a final volume of 100 µl. The nucleotide mix, 
primers and water supplied by the kit were allowed to thaw on ice and the enzyme left 
in the -20ºC freezer. The DNA template was then denatured by heating in boiling 
water bath for 5 minutes before chilling on ice. The labeling reaction was set up as 
shown in table 8 below. The enzyme was added last to the reaction and gently mixed 
by pipetting up and down using filtered pipette tips. The reaction was incubated at 37 
ºC for 1 hour and stopped by adding EDTA to a final concentration of 20 mM. The 
labeled probes were then stored in the dark at -20ºC. 
 
Reagent Final concentration 
DNA template 50 ng 
Nucleotide mix 10 µl 
Primers 5 µl 
Enzyme solution (5u/µl) 1 µl 
Water q.s to 50 µl 
Table 8. Reaction mix for labeling reaction 
 
3.7.4 Southern Blot 
The restriction enzymes treated DNA was loaded onto a 0.8 % agarose gel and 
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subjected to electrophoresis at 100 V for 80 minutes. This was to allow for sufficient 
separation of the DNA fragments. The gel was then viewed under a UV trans-
illuminator and any redundant gel removed. A picture was also quickly taken for 
future reference. The DNA in the gel was then depurinated by washing the gel in 250 
mM hydrochloric acid for 10 minutes with gentle agitation. After depurination, the 
DNA was denatured using denaturation buffer (appendix) for 25 minutes with gentle 
agitation before neutralizing with neutralization buffer (appendix). Adequate buffer to 
cover the gel was added for these three steps and a rinse step with distilled water was 
included in between washes. The DNA was then transferred onto a marked nylon 
membrane (Amersham Biosciences) by capillary action. To do this, the gel was first 
placed face down onto 3 mm Whatman paper acting as a wick in a reservoir 
containing 10 X SSC buffer. The nylon membrane which was approximately larger 
than the gel by 1 cm in both width and length was positioned on top of the gel with 
the marked surface facing up. Six pieces of 3 mm Whatman paper cut to the size of 
approximately 1 cm smaller than that of the nylon membrane in both width and length 
was placed on top of the nylon membrane. Lastly, stacks of paper towels cut to about 
0.5 cm smaller than the 3 mm Whatman paper and stacked up to a height of 
approximately 5 cm was placed on the six pieces of 3 mm Whatman paper. A weight 
was then placed on top to provide pressure and capillary transfer was allowed to 
proceed overnight. 
 
The next day, the capillary apparatus was disassembled and the DNA was fixed onto 
the nylon membrane by cross-linking. Cross-linking was done by subjecting the 
membrane (marked surface facing down) to UV (VilberLourmat BLX-254, 0.120 
joules). The hybridization buffer (appendix) was thawed and pre-heated to 60ºC using 
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a hybridization oven. The amount of hybridization buffer used was about 0.125 ml per 
cm2 of membrane. After cross-linking, the blot was wetted using 5X SSC buffer and 
transferred to the hybridisation buffer for a pre-hybridisation step of approximately 4-
5 hours. The labeled probed were thawed and denatured by heating in a boiling water 
bath for 5 minutes before chilling in ice. The amount of probe added was dependent 
on the volume of the hybridization buffer, with the concentration of probe added 
roughly about 10 ng per ml of hybridisation buffer used. Care was also taken to make 
sure that the probes were not added directly onto the membrane. Hybridisation was 
allowed to take place in the oven at 60ºC overnight. After the hybridization step, the 
membrane was subjected to a stringency wash using 1 X SSC, 0.1 % SDS at 60ºC for 
5 minutes with a total of 3 washes. Fresh buffer was used for every wash. A second 
stringency wash using 0.5 X SSC, 0.1 % SDS was also conducted for 5 minutes with 
a total of 3 washes at 60ºC. Fresh buffer was also used for every wash. After the 
stringency washing step, the membrane was placed in blocking buffer and incubated 
at room temperature with shaking for 1 hour, before transferring the membrane to the 
antibody binding solution. Approximately 0.75 ml to 1.0 ml of blocking buffer per 
cm2 of membrane was used and approximately 0.3 ml of antibody binding buffer per 
cm2 of membrane was used. The antibody was diluted 5000 fold in the antibody 
binding solution. Subsequently, the membrane was washed with 0.3 % (v/v) Tween 
20 in buffer A (appendix) for a total of 3 washes each 10 minutes long, using fresh 
wash buffer in between washes. Excess wash buffer was removed by touching the 
corner of the membrane onto a clean piece of cling wrap and placed on a flat clean 
plastic tray. The amount of detection reagent added was approximately 40 µl per cm2 
of membrane and left at room temperature for 2 to 5 minutes. Excess detection 
reagent was drained off by again touching the corner of the membrane onto a clean 
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piece of cling wrap and transferred into a clean hybridization bag and heat sealed. The 
bag containing the membrane was then exposed to film (Fujifilm) in a dark room for 
an appropriate amount of time and developed using the developer found in CRC 
(Kodak) 
  
3.7.5 Northern Blot 
As RNA is susceptible to degradation to RNase which can be found on un-clean 
surfaces or hands, gloves were worn throughout the entire procedure and all apparatus 
used were cleaned with RNaseZap (Amersham). RNase-free 1.5 ml and 2.0 ml 
microcentrifuge tubes (Axygen) were used and only RNase free water or milliQ grade 
water was used to prepare buffers and reactions. A 0.8 % FA gel containing 4% 
formaldehyde (appendix) was cast and placed in running buffer (appendix). The RNA 
samples were then mixed with sample loading dye (appendix) before heated at 60ºC 
for 15 minutes to remove any secondary RNA structures. After heating, the samples 
were loaded into the gel and subjected to electrophoresis at 80 V until the 
bromophenol blue dye had ran to a suitable distance in the gel. Lanes containing the 
RNA samples were excised using a clean surgical blade and washed with excess 
RNase free water with gentle agitation for 30 minutes to dilute out the formaldehyde. 
The gel was then washed in Alkaline Buffer A (appendix) for 30 minutes with gentle 
agitation before neutralizing with Neutralization buffer A (appendix) for 30 minutes 
with gentle agitation. All the wash steps were done in room temperature. Finally, the 
gel was soaked in 10 X SSC buffer for 5 minutes. This step was repeated once using 
fresh 10 X SSC buffer. To transfer the RNA from to gel to a nylon membrane, the gel 
was first placed face down onto 3 mm Whatman paper acting as a wick in a reservoir 
containing 10 X SSC buffer. The nylon membrane which was approximately larger 
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than the gel by 1 cm in both width and length was positioned on top of the gel with 
the marked surface facing up. Six pieces of 3 mm Whatman paper cut to the size of 
approximately 1 cm smaller than that of the nylon membrane in both width and length 
was placed on top of the nylon membrane. Lastly, stacks of paper towels cut to about 
0.5 cm smaller than the 3 mm Whatman paper and stacked up to a height of 
approximately 5 cm was placed on the six pieces of 3 mm Whatman paper. A weight 
was then placed on top to provide pressure and capillary transfer was allowed to 
proceed overnight. 
 
The next day, the capillary apparatus was disassembled and the RNA was fixed onto 
the nylon membrane by cross-linking. Cross-linking was done by subjecting the 
membrane (marked surface facing down) to UV. The hybridization buffer (appendix) 
was thawed and pre-heated to 65ºC using a hybridization oven. The amount of 
hybridization buffer used was about 0.125 ml per cm2 of membrane. After cross-
linking, the blot was wetted using 5 X SSC buffer and transferred to the hybridisation 
buffer for a pre-hybridisation step of approximately 4-5 hours. The labeled probes 
were thawed and denatured by heating in a boiling water bath for 5 minutes before 
chilling in ice. The amount of probe added was dependent on the volume of the 
hybridization buffer, with the concentration of probe added roughly about 10 ng per 
ml of hybridisation buffer used. Care was also taken to make sure that the probes were 
not added directly onto the membrane. Hybridisation was allowed to take place in the 
oven at 65ºC overnight. After the hybridization step, the membrane was subjected to a 
stringency wash using 1 X SSC, 0.1 % SDS at 60ºC for 5 minutes with a total of 3 
washes. Fresh buffer was used for every wash. A second stringency wash using 0.1 X 
SSC, 0.1 % SDS was also conducted for 5 minutes with a total of 3 washes at 65ºC. 
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Fresh buffer was also used for every wash. After the stringency washing step, the 
membrane was placed in blocking buffer and incubated at room temperature with 
shaking for 1 hour, before transferring the membrane to the antibody binding solution. 
Approximately 0.75 ml to 1.0 ml of blocking buffer per cm2 of membrane was used 
and approximately 0.3 ml of antibody binding buffer per cm2 of membrane was used. 
The antibody was diluted 5000 fold in the antibody binding solution. Subsequently, 
the membrane was washed with 0.3 % (v/v) Tween 20 in buffer A (appendix) for a 
total of 3 washes each 10 minutes long, using fresh wash buffer in between washes. 
Excess wash buffer was removed by touching the corner of the membrane onto a 
clean piece of cling wrap and placed on a flat clean plastic tray. The amount of 
detection reagent added was approximately 40 µl per cm2 of membrane and left at 
room temperature for 2 to 5 minutes. Excess detection reagent was drained off by 
again touching the corner of the membrane onto a clean piece of cling wrap and 
transferred into a clean hybridization bag and heat sealed. The bag containing the 
membrane was then exposed to film (Fujifilm) in a dark room for an appropriate 
amount of time and developed using the developer found in CRC (Kodak). 
 
  
3.7.6 Reprobing of membrane 
Prior to reprobing, the membrane is soaked in 5 X SSC for 1-2 minutes. After soaking, 
the membrane is added to boiling 0.1 % (w/v) SDS for 10 minutes with shaking, using 
approximately 5 ml of SDS per cm2 of membrane. The procedure is performed a total 
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3.8 In-vitro transcription 
In-vitro transcription was done using Promega’s HelaScribe® Nuclear Extract in vitro 
Transcription System. The reaction was set up as recommended in the manufacturer’s 
protocol, as shown in table 9 below. rNTPs were added last with a preincubation 
period of 30 minutes at 30ºC consisting of just the template, MgCl2, nuclear extract, 
transcription buffer and RNase free water. This was to allow the transcription 
complex to first bind onto the promoters. After 30 minutes of pre-incubation, rNTPs 
were added and incubated at 30ºC for a specified time.  
 
Reagent Final concentration 
Hela Nuclear Extract 1X transcription buffer 7.4 µl 
Nuclear extract 3.6 µl 
MgCl2  8 µM 
Template DNA 24 ng/µl 
RNase free water q.s 25 µl 
rNTPs as specified in text 
Table 9. Reaction mix for in-vitro transcription 
 
After the reaction, any RNA transcripts were isolated according to the manufacturer’s 




3.8.1 In-vitro transcription optimization experiments 
Two optimization experiments were first conducted to help identify the optimal 
conditions for in-vitro transcription. A time course study as well as rNTP 
concentration optimization experiment was carried out, using pEGFP-lacZ as the 
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template DNA. For both experiments, 600 ng of template was added per 25 µl 
reaction volume. 
 
3.8.1.1 Preparation of template DNA 
pEGFP-lacZ digested with the suitable restriction enzymes for use as template. 10 µg 
of plasmid DNA was digested in a final reaction volume is 50 µl. The digested 
plasmid was then purified using the Qiagen QiaQuick PCR purification procedure 
(section 3.1.3) and placed in -20ºC freezer for long term storage. 
 
3.8.1.2 Time course study 
The in-vitro transcription reaction was set up as described above in section 3.8 and 
table 8. Upon addition and mixing of rNTPs, an initial aliquot was taken at 30 seconds. 
The reaction was incubated at 30ºC. Aliquots were taken at 5, 10, 15, 20, 25, 30, 45, 
60, 75 and 90 minutes and transferred to separate tubes containing stop buffer 
(appendix) to terminate the reaction. Northern blot analysis was done as described in 
section 3.5.5. 
 
3.8.1.3 rNTP concentration optimization experiment 
The in-vitro transcription reaction was set up as described above in section 3.8 and 
table 8. The concentrations of rNTPs used were 10 µM, 25 µM, 50 µM, 100 µM, 200 
µM and 400 µM. The reaction was allowed to proceed at 30ºC for 20 minutes before 
the addition of an equal volume of 40 µM EDTA to terminate the reaction. RNA 
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3.9 Size exclusion chromatography  
To determine if the RNA generated from in vitro transcription is free or in large 
molecular complexes, size exclusion chromatography was performed using 
Sephacryl-S1000 (Amersham). The column was packed into 1 ml sterile pipettes 
(Falcon). A 1 ml pipette tip was used as the reservoir. Elution was by gravity and the 
fractions collected manually into nuclease free 1.5 ml microcentrifuge tubes.  
 
3.9.1 Packing and calibration of the column 
The Sephacryl-S1000 beads were first re-suspended in elution buffer (appendix). 
Before casting the column, the cotton stopper in the 1 ml sterile pipette was first re-
positioned to the tip of the pipette using a vacuum pump. The tip of the pipette was 
further shortened so as to reduce the dead space under the column. This was to 
minimize band broadening, which happens when the eluate undergoes non-laminar 
flow within this dead space. RNaseZAP ® (Ambion) was first applied to the openings 
of the column to remove any possible RNase contamination. A schematic diagram of 
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Fig. 5. Schematic diagram of column used for size exclusion chromatography 
After packing, the column was first calibrated before it could be used for size 
exclusion chromatography. 2 X the column length of elution buffer was allowed to 
flow through the column by gravity before the sample was loaded.  
 
3.9.2 Loading of sample onto column 
As the meniscus of the liquid phase reached the top surface of the column, the sample 
was quickly but carefully loaded. The sample was then allowed to flow into the 
column before more elution buffer was added.  
 
3.9.2.1 Collection of fractions and nucleic acid precipitation 
Fraction collection only started on the 21st drop. The fractions were collected into 
nuclease free 1.5 ml microcentrifuge tubes containing 0.3 M NaAc and 20 µg of yeast 
tRNA. After collection, the fractions were subjected to phenol:chloroform treatment 
to remove any contaminating proteins. 1 X final fraction volume of 
phenol:chloroform was added to each fraction and vortexed for 1 minute before 
centrifuging at 14,000 rpm for 5 minutes. After centrifugation, the aqueous layer was 
carefully removed and placed in a new nuclease-free 1.5 ml microcentrifuge tube. 2.5 
X the aqueous layer volume of absolute ethanol was added and the fractions were then 
Column beads Sephacryl-S1000 
packed by gravity 
1ml sterile pipette tip used as reservoir 
Cotton stopper of 1ml disposable sterile pipette re-
positioned to the pipette tip using vacuum pump 
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stored at -70ºC for at least 15 minutes, before being centrifuged at 14,000 rpm for 15 
minutes at 4ºC. After centrifugation, the supernatant was carefully removed by 
aspiration. 300 µl of 70% ethanol was added as a washing step to remove any 
phenol:chloroform carryover. After adding 300 µl of 70% ethanol, the fractions were 
again centrifuged at 14,000 rpm for 15 minutes before the supernatant removed by 
aspiration, with care taken to ensure that the RNA pellet was not accidentally 
removed at the same time. The precipitated nucleic acid pellet was allowed to air dry 
for 10 minutes before being resuspended in 5µl of 1 X NEB Buffer 2. The 
resuspended RNA pellet was further treated with RNase-free DNase I as described in 
section 3.7.2. 1 µl of the treated was then used for Northern Blot analysis as described 
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4.1 Replication of EBV oriP-containing plasmids in EBNA-1-expressing cells 
During the latent infection stage of the Epstein-Barr Virus (EBV), only two 
components of the virus are needed for replication. The latent origin of replication 
oriP, together with the Epstein-Barr virus nuclear antigen (EBNA-1) have been shown 
to be capable of mediating the replication and long-term persistence of the virus 
genome as an episome in the host cell (Yates et al., 1984), making sure that the 
episome replicates synchronously once per cell cycle and is properly partitioned into 
daughter cells. In this study, I first placed oriP in varying locations and orientations in 
the pcDNA3.1+ plasmid (Invitrogen) and made selective deletions of various 
promoters from the plasmid to understand the effect of transcription on replication in 
vivo. The useful plasmids constructed and their distinctive features are listed in table 
10 below. The structural elements of these plasmids and their parent plasmid 
pcDNA3.1+ are depicted in figures 6 to 10.  
 
Name Distinctive features 
p-oriP-S oriP outside transcription unit 
p-S-oriP oriP inside transcription unit: FR more proximal to the promoter than DS 
p-S-oriP.1 oriP inside transcription unit: DS more proximal to the promoter than FR 
p-oriP-∆S Without known transcription promoter (SV40-promoter deleted) 
 
Table 10. Plasmids designed for in vivo study of effect of transcription on oriP-
dependent replication. A transcription unit is defined as the region from a 
transcription enhancer/promoter to the downstream polyadenylation signal. The 
promoter for the transcription unit in the first three plasmids listed is the SV40 early 
promoter. The plasmids listed do not contain the CMV immediate early promoter, 
which is present in their parent plasmid pcDNA3.1+ but removed during their 





           




Beta-lactamase gene CMV promoter
pUC ori
F1 ori






























Figure 6. Map of plasmid pcDNA3.1+. This plasmid contains a CMV immediate 
early promoter that is used for expressing the gene of interest, and SV40 early 
promoter that drives the expression of the neomycin phosotransferase gene for 
selection in transfected mammalian cells. Important restriction enzyme sites are 
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poriP w/o BZLF promoter
6673 bp
Beta-lactamase gene
SV40 promoter and ori
pUC ori
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Figure 7. Map of plasmid p-oriP-S. In this construct, the CMV promoter was 
removed from pcDNA3.1+. OriP was inserted outside of the SV40-promoter-driven 
transcription unit and approximately 2 kb downstream of the SV40 polyadenylation 
signal. Important restriction enzyme sites are shown and their positions on the 




















Xho I (2234) 
Eco RV (2213) 
Eco RI (2201) 
Sac II (6) 
           















Nde I (1265)30de I (1 35)9I (148 )547
Nde I (1661) 721)de I (1811)I (1 7














Figure 8. Map of plasmid p-S-oriP. In this construct, the CMV promoter was also 
removed from pcDNA3.1+ whereas the oriP was inserted into the SV40-promoter-
driven transcription unit. The FR is closer to the SV40 promoter; located about 73 
base pairs downstream while the DS is located approximately 1.9 kb further 
downstream. Important restriction enzyme sites are shown and their positions on the 




















           

































Figure 9. Map of plasmid p-S-oriP.1. This construct is similar to p-S-oriP, except 
that the orientation of oriP is different. In this case, the DS is closer to the SV40 
promoter, located approximately 400 base pairs downstream, while the FR is 
approximately 1.5 kb further from the promoter. Important restriction enzyme sites 
are shown and their positions on the plasmid in parenthesis. For Nde I sites, only the 
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Figure 10. Map of plasmid p-oriP-∆S. In this construct, both the CMV and SV40 
promoters were removed, thus eliminating any form of possible eukaryotic 
transcription on this vector. Important restriction enzyme sites are shown and their 
positions on the plasmid in parenthesis. For Nde I sites, only the position of the first 
and last sites are shown.  
 
4.1.1 Construction of oriP-containing plasmids  
 
4.1.1.1 Amplification of oriP DNA 
A 2.4 kb EBV genomic DNA containing the latent origin of replication oriP (figure 
11) was amplified from a known EBV containing cell line B95-8. Whole cell genomic 
DNA was isolated as described in section 3.6.2 and PCR amplification was performed 
on the genomic DNA as described in section 3.1.1. After PCR, 2 µl of the PCR 
product was loaded onto a 0.8 % agarose gel for electrophoresis at 100 V for 1 hour. 
After electrophoresis, the gel was viewed under UV light and a picture of the PCR 
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Figure 11. Map of oriP-containing EBV genomic fragment to be PCR-amplified 
and cloned in this study. Some important restriction enzyme sites are shown. They 
were located based on EBV B95-8 strain genomic sequence (GENBANK Accession 











Figure 12. PCR-amplified oriP-containing EBV genomic fragment. (A): Lane 1 is 
λHindIII DNA ladder; lane 2 is the PCR-amplified oriP-containing EBV genomic 
fragment. 
 
As can be seen from the above figure, a PCR product of the expected size was 
obtained. Restriction analysis using Nde I was done and confirmed the identity of the 
PCR product and this result can also be seen in all later restriction enzyme analyses of 
all oriP containing plasmids using Nde I. Sequencing of the oriP fragment was 
performed but while I was able to confirm the presence of oriP sequences, I was 
unable to obtain clean sequencing results because of the presence of numerous repeat 
6)Aat II Sac II 
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sequences of EBNA-1 binding sites. In addition, the original aim of the project is to 
study the effect of transcription on oriP’s ability to allow replication in the presence 
of EBNA-1. What was really needed was a functional oriP that is able to initiate 
replication and it was not necessary to confirm every base pair of the oriP. The Nde I 
digestion serves as a way of confirming the presence of oriP in each vector construct. 
As will be demonstrated below, the presence of oriP on plasmid vector clearly 
allowed replication, indicating a functional oriP. 
  
4.1.1.2 pcDNA3.1+  
pcDNA3.1+ was digested with restriction enzymes Stu I and Sal I for downstream 
reactions. After digestion, the fragments were analyzed using 0.8 % agarose gel 
electrophoresis. A photo of the gel can be seen in figure 13 below. 
 








Figure 13. Restriction analysis of plasmid pcDNA3.1+. Lane 1 is 1kb DNA ladder 
(Promega) Lane 2 is undigested pcDNA3.1+ plasmid; Lane 3 is pcDNA3.1 digested 
with Stu I; Lane 4 is pcDNA3.1+ digested with Sal I; Lane 5 is λ HindIII. 
 
As expected from the plasmid map (figure 6), Stu I cleaves pcDNA3.1+ at one site 
resulting in a linear band corresponding to 5.4 kb in size. Sal I cleaves pcDNA3.1+ at 









           




To construct the initial plasmid containing oriP, the 2.4 kb oriP-containing EBV 
genomic fragment (section 4.1.1.1) and the pcDNA3.1+ vector were digested with 
restriction enzymes Aat II and Eco RI. After digestion, the products were purified, 
ligated and transformed into electrocompetent DH10B Escherichia coli cells. Plasmid 
DNA was purified from a few transformants and analyzed by Nde I digestion. An 
isolate with the restriction pattern expected of the cross-ligation product was kept for 
further construction described below. 
 
The initial oriP-containing plasmid described above contained the transcription 
promoter for the EBV ORF BCRF1 (figure 11). Although this promoter requires 
activation by a viral transcription activator, which is not normally expressed in the 
cell line B95-8 that I used in this study, it is better to remove this promoter to 
eliminate the possibility of undesired transcription initiated from it. The BCRF1 was 
included in the original PCR product as it was difficult to design PCR primers within 
the exact oriP region. It was therefore an easier strategy to include the BCRF1 ORF 
and remove it later by restriction enzymes. Sequence analysis showed that this 
promoter is closely flanked by the unique Aat II and Sac II sites in the initial oriP-
containing plasmid. To construct p-oriP-S, the desired oriP-containing plasmid 
without the BCRF1 promoter, the initial oriP-containing plasmid DNA was first 
digested with Aat II and Sac II. The large fragment resulted from the digestion was 
purified, subjected to T4 polymerase blunt end repair, purified again and finally self-
ligated before transforming into DH10B electrocompetent Escherichia coli cells. 
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Plasmid DNA was purified from a few transformants and subjected to restriction 
enzyme analysis.  
 
Single digests using the restriction enzymes Nde I, Aat II, Stu I and Sal I of a positive 
isolate are shown in figure 14 below. As expected from the plasmid map (figure 7), 
Nde I digestion yielded small fragments that are visualized as a smear near the bottom 
of lane 2, indicative of the EBNA-1 binding sites on the oriP, the 1.1 kb fragment 
between DS and FR and a larger 4.9 kb band from the vector. Due to the T4 
polymerase blunt end repair, the Aat II site was destroyed after ligation with the 
repaired Sac II site and the plasmid was not cleaved by Aat II. As expected, both Sal I 
and Stu I cleaved the plasmid once, resulting in a 6.6 kb band.  









Figure 14. Restriction analysis of plasmid p-oriP-S. Lanes 1 and 7 are λ HindIII 
and 1 kb DNA ladder respectively. Lane 2 is undigested p-oriP-S; Lane 3 is p-oriP-S 
digested with Nde I; Lane 4 is p-oriP-S digested with Aat II; Lane 5 is p-oriP-S 
digested with Stu I; Lane 6 is p-oriP-S digested with Sal I 
 
4.1.1.4 p-S-oriP and p-S-oriP.1 
To construct p-S-oriP and p-S-oriP.1, the precursor plasmid pcDNA3.1+∆C, i.e. 








           
Results                        
 68
The CMV promoter of pcDNA3.1+ was removed by digesting the plasmid with Aat II 
and Kpn I. The largest product of the reaction was purified and the incompatible ends 
treated with T4 polymerase. After that, the reaction product was purified again, 
followed by self-ligation and transformation. Plasmid DNA purified from positive 
transformants that showed resistance to Aat II and Kpn I and other expected 
restriction patterns were directly used for the construction of both p-S-oriP and p-S-
oriP.1. The oriP-containing DNA fragment was extracted from the initial oriP-
containing plasmid DNA used to construct p-oriP-S (section 4.1.1.3) with restriction 
enzymes Sac II and Xba I and further treated with T4 polymerase to blunt the ends. 
pcDNA3.1+∆C DNA was linearized using Sma I, a blunt end cutter that cleaves just 
downstream of the SV40 promoter. The blunt-end oriP-containing fragment was then 
ligated to the linearized pcDNA3.1+∆C and the ligation product was used to 
transformed DH10B cells. Since these two blunt-end reactants can be ligated in two 
opposite relative orientations, the two desired constructs, p-S-oriP and p-S-oriP.1, 
could be obtained from a single reaction. Plasmid DNA was purified from a few 
transformants and analyzed using the restriction enzymes Nde I, Eco RI and Sal I. 
Agarose gel electorphoresis was performed to analyze the restriction fragments. 
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Figure 15. Restriction analysis of plasmids p-S-oriP and p-S-oriP.1. Both 
plasmids were digested with the restriction enzymes Nde I, Eco RI and Sal I. Lanes 1 
and 11 are λ HindIII DNA ladders. Lane 6 is 1kb ladder. Lane 2: undigested p-S-oriP; 
Lane 3: p-S-oriP digested with Nde I; Lane 4: p-S-oriP digested with Eco RI; Lane 5: 
p-S-oriP digested with Sal I; Lane 7: undigested p-S-oriP.1; Lane 8: p-S-oriP digested 
with Nde I; Lane 9: p-S-oriP.1 digested with Eco RI; Lane 10: p-S-oriP digested with 
Sal I. 
 
As can be seen from the gel photograph and plasmid maps (figures 8 and 9), upon 
digestion with Nde I, both plasmids yield small molecular weight bands that appear as 
a smear due to the multiple Nde I restriction enzyme sites on both plasmids, indicative 
of the presence of oriP. Eco RI digestion of p-S-oriP yielded two bands, a larger 5.6 
kb band and a smaller 1.1 kb band due to the orientation of oriP. It can be seen that 
for p-S-oriP, the FR is closer to the promoter while the DS is further away. From the 
gel photograph, it would appear that Eco RI digestion of p-S-oriP.1 yielded only a 
single band corresponding to 3.3 kb in length. In fact, there are two equal molecular 
weight bands, each 3.3 kb long due to the position of the Eco RI sites on p-S-oriP.1 as 
evidenced from the plasmid map (figure 9), which indicates that the DS is closer to 
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both plasmids.  
  
4.1.1.5 p-oriP-∆S 
To construct p-oriP-∆S, the precursor plasmid pcDNA3.1+∆CS, i.e. pcDNA3.1+ with 
both CMV immediate early and SV40 immediate promoters removed, was first 
constructed. To construct pcDNA3.1+∆CS, the SV40 early promoter-containing Eco 
RV-Sma I fragment was removed from pcDNA3.1+∆C (described in section 4.1.1.4). 
The construction of p-oriP-∆S from pcDNA3.1+∆CS was done in the same way as the 
construction of p-S-oriP and p-S-oriP.1 from pcDNA3.1+∆C described in 4.1.1.4. The 
results of the restriction enzyme analysis of a positive isolate using Nde I, Sma I, Sal I 
and Stu I are shown in figure 16 below. 
 









Figure 16. Restriction analysis of plasmid p-oriP-∆S. Nde I, Sma I, Sal I and Stu I 
were used to digest the plasmid. Lane 1: 1kb DNA ladder; Lane 2: undigested p-oriP-
∆S; Lane 3: p-oriP-∆S digested with Nde I; Lane 4: p-oriP-∆S digested with Sma I; 
Lane 5: p-oriP-∆S digested with Sal I; Lane 6: p-oriP-∆S digested with Stu I; Lane 7: 
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As can be seen from the above figure, Nde I digestion of p-oriP-∆S yielded small 
fragments from the multiple Nde I enzyme sites, a 1 kb band and a larger 3.8 kb 
fragment, which corresponds to the expected digestion pattern from the plasmid map 
(figure 10). Sma I digestion yielded two fragments: a 900 bp and a larger 4.7 kb band. 
As there is only one Sal I site on the plasmids, Sal I digestion gave an expected 5.6 kb 
fragment. As the SV40 promoter was removed, the plasmid is now expectedly 
resistant to cleavage by Stu I. The orientation of oriP in this clone is not expected to 
matter as there is not promoter upstream of the oriP and therefore only one clone was 
used for subsequent experiments. For better comparisons, I chose the one with the 
relative orientation of different components the same as that in p-oriP-S and that in p-
S-oriP.1 too. 
 
4.1.2 Replication of p-oriP-S in EBNA1-expressing cells  
Replication of transfected plasmid DNA in mammalian cells can be assayed 
conveniently based on the change in DNA methylation pattern. Plasmid DNA 
synthesized by a Escherichia coli strain expressing DAM methylase is methylated by 
the enzyme at the adenosine residue in the specific DNA sequence 5’-GATC-3’. 
Mammalian cells do not possess DAM methylase and therefore the DNA synthesized 
by them is not methylated this way. The restriction enzyme Dpn I has the same 
sequence specificity as DAM methylase and it cleaves DNA only if the adenosine 
residue in its recognition site is methylated. To assay for plasmid DNA replication in 
mammalian cells, plasmid DNA carrying Dpn I recognition sites is prepared from 
DAM-positive bacterial cells and transfected into mammalian cells. Plasmid DNA is 
then recovered from the transfected cells after a suitable time of growth and digested 
with Dpn I. DNA replicated in mammalian cells is identified by its resistance to Dpn I. 
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All the plasmids used in this study contain multiple Dpn I recognition sites. 
 
Once the p-oriP-S plasmid was constructed, its ability to replicate in EBNA1-
expressing mammalian cells was analyzed, with its parent plasmid pcDNA3.1+ as a 
negative control. A time course was done to understand the kinetics of its replication. 
Thus, 20 µg of p-oriP-S and pcDNA3.1+ were transfected separately into EBNA-1 
expressing B95-8 cells as described in section 3.6.3 using 250 V and 950 µF. The 
transfected cells were allowed to grow at 37 ºC, 5 % CO2. For each transfection, 
plasmid DNA was harvested from 5 X 105 cells at 48, 72 and 96 hours post-
transfection as described in section 3.7.2. The recovered plasmid DNA was then 
linearized using an appropriate restriction enzyme. An aliquot of it was further 
digested by Dpn I. The so-treated plasmid DNA samples were subjected to Southern 
blot analysis using neomycin phosotransferase gene specific probes as described in 
section 3.7.4. Various amounts of EcoR I linearized pcDNA3.1+ plasmid were 











           













Figure 17. Kinetics of replication of p-oriP-S in EBNA-1 expressing cells. 
Southern blot analysis of plasmid DNA recovered from transfected cells. (+): Dpn I 
treated; (-): Non-Dpn I treated. Lanes 1-2: p-oriP-S recovered after 48 hours; Lanes 3-
4: pcDNA3.1+ recovered after 48 hours; Lanes 5-6: p-oriP-S recovered after 72 hours; 
Lanes 7-8: pcDNA3.1+ recovered after 72 hours; Lanes 9-10: p-oriP-S recovered after 
96 hours; Lanes 11-12: pcDNA3.1+ recovered after 96 hours; Lane 13: 1 ng of 
linearised pcDNA3.1+; Lane 14 300 pg of linearized pcDNA3.1+; Lane 15: 100 pg of 
linearized pcDNA3.1+; Lane 16: 30 pg of linearized pcDNA3.1+. For lanes 1 to 12, 
each lane contains plasmid DNA recovered from the same number of transfected cells. 
 
Replicated plasmid DNA in the Dpn I-digested sample should have a size of the full-
length plasmid because of its resistance to Dpn I digestion, whereas the input plasmid 
DNA should be digested to smaller fragments. As expected, there was no full-length 
pcDNA3+ left after Dpn I digestion (lanes 4, 8 & 12), showing that pcDNA3+ did not 
replicate at all throughout the 96 hours in B95-8 cells. On the other hand, some full-
length p-oriP-S remained after Dpn I digestion (lanes 2, 6 & 10) showing that p-oriP-
S had replicated in B95-8 cells, as expected. Since the oriP-containing EBV genomic 
sequence is the only additional sequence in p-oriP-S relative to pcDNA3.1+, 
replication of p-oriP-S is most probably dependent on oriP. To estimate roughly the 
48 hours 72 hours 96 hours Standard 
p-oriP-S    pcDNA3.1+   p-oriP-S     pcDNA3.1+   p-oriP-S     pcDNA3.1+         pcDNA3.1+ 
4.3kb 
9.5kb
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percentage of replicated p-oriP-S plasmid DNA in each time point, the intensities of 
the full-length plasmid DNA signals from Dpn I-digested and undigested samples 
were compared by naked eye with reference to the signal intensities of the 
pcDNA3.1+ DNA standards on X-ray films exposed for various times to the 
chemilluminescently probed blot. In this estimation, roughly 10% of the plasmids 
recovered from the transfected B95-8 cells were replicated at 48 hours post-
transfection (lanes 1 & 2), while approximately 30% of plasmids were replicated at 72 
hours post-transfection (lanes 5 & 6). Almost 100 % the plasmids were replicated at 
96 hours post-transfection (lanes 9 & 10). Since 72 hours post-transfection appeared 
to be the midway through the accumulation of the replicated plasmid DNA in the 
transfected cells, this time point was chosen to be the time for plasmid recovery from 
the transfected cells in the subsequent analyses of the replication efficiency of 
different plasmid constructs. Since real-time PCR analysis is more quantitative, I 
originally attempted to use it in conjunction with DpnI digestion to measure the 
amount of replicated DNA. This attempt failed because of two reasons. First, I was 
unable to design suitable primers amplifying for a region in oriP due to the highly 
repetitive nature of oriP as well as the lack of Dpn I sites within amplifiable regions. 
Second, when I used the bacterial backbone of the plasmids as the amplicon, the 
background amplification was unacceptably high due to the contamination with 
bacterial plasmid from the laboratory environment. 
 
4.1.3 Replication of oriP-containing plasmids is negatively influenced by the 
presence of transcription promoter in the replicon 
To study the effect of transcription on oriP-dependent DNA replication, 20 µg of the 
each following plasmids, p-oriP-S, p-S-oriP, p-S-oriP.1 and p-oriP-∆S, was 
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transfected separately into EBNA-1 expressing B95-8 cells as described in section 
3.6.3 using 250 V and 950µF. The cells were allowed to grow at 37ºC, 5% CO2 for 72 
hours. Plasmid DNA was then recovered from the transfected cells as mentioned in 
section 3.7.2. An aliquot of the recovered plasmid DNA was treated with Dpn I. 
Southern blot analysis was performed on the Dpn I-treated and untreated plasmid 
DNA and the results can be seen in figure 18 below. 
 







                                      
 
Figure 18. Replication efficiencies of pcDNA3.1+-derived oriP-containing 
plasmids. Southern blot analysis of plasmid DNA recovered from transfected cells. 
(+): Dpn I treated (-): Non-Dpn I treated. Lanes 1 and 2 contain rescued pcDNA3.1+ 
vector; lanes 3 and 4 contain p-S-oriP; lanes 5 and 6 contain p-S-oriP.1; lanes 7 and 8 
contain p-oriP-∆S; lanes 9 and 10 contain p-oriP-S. All lanes contain plasmid DNA 
recovered from the same number of transfected cells. 
 
As can be seen from the Southern blot analysis (figure 18), 72 hours after transfection 
in EBNA-1 expressing cell, parental vector pcDNA3.1+ exhibited no signs of 
replication (lane 2) while all oriP-containing plasmids replicated to certain extent 
(lanes 4, 6, 8 and 10). These results suggest that the plasmid replication observed is 
dependent on oriP. P-oriP-∆S does not contain any known transcription promoter. Its 
pcDNA3.1+  p-S-oriP  p-S-oriP.1   p-oriP-∆S   p-oriP-S 
4.3kb 
9.5kb 
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ability to replicate shows that oriP-dependent DNA replication does not require 
concomitant transcription anywhere in the replicon. In fact, p-oriP-∆S exhibited a 
higher level of replication (roughly 60% of total plasmid replicated) than the other 
oriP-containing plasmids which contain the strong SV40 early promoter (compare 
lane 8 with lanes 4, 6 and 10). These results suggest that the presence of a promoter 
on the plasmid negatively influences the ability of oriP to induce replication. Among 
the plasmids containing the SV40 early promoter, p-oriP-S consistently showed 
higher level of replication (approximately 30 % of total plasmid replicated) than p-S-
oriP and p-S-oriP.1, while the latter two showed similar levels of replication 
(approximately 10% of total plasmid replicated). In p-oriP-S, oriP is located outside 
of the only transcription unit on the plasmid and is more than 2-kb downstream of the 
relevant polyadenylation signal. It is likely that most of the transcription complexes 
have fallen off the DNA template before reaching oriP or been destabilized when they 
reach oriP. On the other hand, in p-S-oriP and p-S-oriP.1, oriP is located within the 
transcription unit and expected to experience heavy traffic of transcription complexes. 
The reduction in the level of replication in these two plasmids compared to that of p-
oriP-S suggests that transcriptional activity at oriP is inhibitory to plasmid replication.  
 
The experiment was repeated once. The results obtained were basically the same. 
 
4.2 Transcription through oriP is inhibited in vivo 
To analyze plasmid transcription in the transfected cells, total RNA was isolated from 
them (section 3.7.2) and northern blot analysis was performed on the isolated RNA 
(section 3.7.5). The analysis was done with neomycin phosphotransferase gene 
sequence-specific probes and the results can be seen in figure 19A below. 
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Figure 19. Transcription of pcDNA3.1+-derived oriP-containing plasmids in 
B95-8 cells. Northern blot analysis of RNA isolated from plasmid transfected cells. 
(A): Northern blot probed with neomycin phosotransferase gene specific probes. (B): 
Blot is stripped of probes and re-probed with GAPDH specific probes. Lane 1: 
pcDNA3.1+; Lane 2: p-S-oriP; Lane 3: p-S-oriP.1; Lane 4: p-oriP-∆S; Lane 5: p-oriP-
S; Lane 6: untransfected B95-8 cells.  
 
Plasmids p-S-oriP and p-S-oriP.1 have oriP inserted upstream of the transcriptional 
start site of the neomycin resistance gene.  Lane 6 is the negative control containing 
total RNA from untransfected cells. As expected, no hybridization signal can be 
observed. According to the sequence of pcDNA3.1+, the neomycin 
phosphotransferase gene transcript produced from this plasmid should be about 1 kb 
in size. As expected, an RNA signal of this size was obtained from the cells 
transfected with pcDNA3.1+ (lane 1). An RNA signal of the same size but much 
higher intensity was obtained from the cells transfected with p-oriP-S (lane 5). This 
observation can be explained by the fact that FR element in oriP is an EBNA1-
dependent transcriptional enhancer (Reisman and Sudgen, 1986). Since FR occurs 
immediately upstream of the SV40 early promoter in p-oriP-S, the transcription of the 
neomycin phosphotransferase gene is enhanced and this lead to the observed intense 
RNA signal obtained from p-oriP-S-transfected cells. No neomycin 
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∆S (lane 4). This is expected because there is no promoter on this plasmid to drive 
transcription. In p-S-oriP and p-S-oriP.1, a 2.1-kb oriP-containing EBV sequence is 
inserted between the SV40 early promoter and the neomycin phosphotransferase gene 
sequence (section 4.1.1.3). There is no known transcription promoter, transcript 
splicing or polyadenylation signal in this sequence insert. Because of this, the 
neomycin phosphotransferase gene sequence-containing transcript produced from 
these two plasmids should be about 3.1 kb in size. Lanes 2 and 3 contain total RNA 
from cells transfected with p-S-oriP and p-S-oriP.1 respectively. Unexpectedly, there 
was very little or no signal corresponding to RNA of this size on these lanes. There is 
a faint band of approximately 1 kb observed in lane 3. The origin of this RNA is 
unknown. Given that the probes used are highly specific for the neomycin transcript 
(as evidenced by the negative control in lane 6), it could probably mean that there is 
possibly a weak cryptic transcriptional promoter occurring in the DS-distal end of the 
FR region. The only way a 3.1kb band can be seen in lanes 2 and 3 is if transcription 
proceeded without disruption through the oriP and into the neomycin resistance gene. 
Any transcripts that terminated within the oriP itself would not generate any signal. 
Figure 21 also presents a summary of the constructs used. To check if the lack of 
expected RNA signal on these two lanes could be caused by unintended RNA 
degradation during the experimental process, the blot was stripped of the neomycin 
phosphotransferase gene-specific probes as described in section 3.7.6 and re-probed 
with the housekeeping cell gene GAPDH gene-specific probes as described in section 
3.7.5. The results are showed in figure 19B. As shown, the intensities of RNA signals 
from all samples are similar, except the one from p-oriPS-transfected cells which is 
somewhat higher. The apparently stronger GAPDH RNA signal from p-oriP-S-
transfected cells could be due to incomplete stripping of neomycin phosphotransferase 
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gene probes. The neomycin phosphotransferase and GAPDH gene transcripts 
obtained from this plasmid are by coincidence of very similar sizes and thus should 
occur on very nearby locations on the Northern blot. The particularly abundant 
neomycin phosphotransferase gene probes hybridized to the corresponding transcripts 
from p-oriP-S-transfected cells (figure 19A, lane 5), if not completely removed, could 
add to the GAPDH signal from the re-probed blot. In any case, GAPDH probing 
shows that RNA isolated from p-SoriP- and pSoriP.1-transfected cells did not suffer 
random degradation. Southern blot analysis shows that the amounts of plasmid DNA 
in p-S-oriP- and p-S-oriP.1-transfected cells were not much different from the 
amounts of plasmid DNA in the cells transfected by other plasmids (compare figure 
18 lanes 3 and 5 with lanes 1, 7 and 9). Therefore, a possible explanation for the 
particular lack of neomycin phosphotransferase gene sequence-containing RNA in p-
S-oriP- and p-S-oriP.1-transfected cells is that the transcription on these two plasmids 
was somehow inhibited and it is the presence of oriP sequence within the 
transcription unit that causes the inhibition.  
 
 
4.2.1 Transcription through oriP in vivo is inhibited even in the absence of 
EBNA-1 
There are two likely mechanisms leading to the observed inhibition of transcription of 
p-S-oriP and p-S-oriP.1 in B95-8 cells. First, transcription elongation is blocked by 
the tight binding of EBNA1 protein its cognate sites in oriP. Second, transcription 
elongation could be inhibited by the head-on replication initiated at oriP. In other 
words, replication and transcription occurring simultaneously on the same DNA 
template can be mutually inhibitory. Since both of these possible transcription 
           




inhibitory mechanisms require EBNA1 protein, they can be tested by comparing the 
efficiencies of transcription in EBNA1-expressing and non-expressing cells.  Thus, 
the same plasmids were transfected into BJAB cells, which do not express EBNA1. 
Total RNA was isolated and northern blot performed using neomycin specific probes. 
The results are shown in figure 20 below. 
 1      2     3     4      5      6 





Figure 20. Transcription of pcDNA3.1+-derived oriP-containing plasmids in 
BJAB cells. Northern blot analysis of RNA isolated from plasmid transfected cells 
using neomycin phosotranasferase gene specific probes. Lane 1: pcDNA3.1+; Lane 2: 
p-S-oriP; Lane 3: p-S-oriP.1; Lane 4: p-oriP-∆S; Lane 5: p-oriP-S; Lane 6: 
untransfected B95-8 cells.  
 
Lane 6 is the negative control containing total RNA from untransfected BJAB cells. 
As expected, no signal was generated. Lane 1 contains RNA from BJAB cells 
transfected with the positive control pcDNA3.1+ parental vector. As expected, a 1 kb 
band identical to that obtained from pcDNA3.1+-transfected B95-8 cells (figure 19A, 
lane 1) can be seen. An RNA signal of the same size was also obtained from p-oriP-S-
transfected BJAB cells (lane 5). Recall that the level of transcription on p-oriP-S was 
much higher than that on pcDNA3.1+ in B95-8 cells because of the EBNA1-
dependent enhancer effect of oriP (compare lanes 1 and 5 of figure 19A). Here in 
BJAB cells which do not express EBNA1, the level of transcription on p-oriP-S was 
not elevated relative to that on pcDNA3.1+ (compare lanes 1 and 5 of figure 20). As 
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4). The main focus of this experiment was the transcription of p-S-oriP and p-S-oriP.1. 
As explained under section 4.2, the neomycin phosphotransferase gene sequence-
containing transcript produced from these two plasmids should be about 3.1 kb in size. 
As can be seen from lanes 2 and 3, very little or no such transcript was produced in 
BJAB cells transfected with these two plasmids. These results are similar to those 
obtained from B95-8 cells (figure 19A, lanes 2 and 3). Therefore, the inhibition of 
transcription in these constructs is independent of EBNA1 protein, and the two 
mechanisms of transcription inhibition suggested above are invalidated. The DNA 
sequence of oriP itself is the likely cause of transcription inhibition. 
 
An interesting scenario that can explain both the inhibition of oriP-dependent 
replication by transcription as well as the inhibition of transcription by oriP in p-S-
oriP and p-S-oriP.1 is that oriP blocks the translocation of transcription elongation 
complexes without dissociating them. In other words, oriP induces transcription arrest. 
Thus, transcription elongation cannot proceed to the neomycin phosphotransferase 
gene sequence occurring downstream of oriP in these plasmids. At the same time, the 
transcription complexes arrested at oriP blocks the initiation and/or elongation of 
replication of these plasmids. The subsequent part of this thesis work was devoted to 
the testing of this possible scenario through in vitro studies. 
 
4.3 In vitro transcription of oriP-containing template 
 
4.3.1 In vitro transcription of pcDNA3.1+, p-oriP-S, p-S-oriP, p-S-oriP.1 and p-
oriP-∆S 
I first tried to see if inhibition of transcription by oriP was reproducible in-vitro. As 
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indicated in section 3.8, in vitro transcription was done using Promega’s HelaScribe® 
Nuclear Extract. In the initial attempts, I carried out in vitro transcriptions using the 
same plasmids employed in the in vivo study. Since polyadenylation machinery was 
not expected to be functional in this in vitro transcription system, the transcription 
templates had to be linear in order to give full-length run-off transcripts of fixed sizes. 
Therefore, the plasmid DNA was first subjected to Sal I restriction enzyme digestion. 
The resulting transcription templates as well as their corresponding run-off transcript 
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Figure 21. In vitro transcription templates and expected transcripts from 
pcDNA3.1+-derived oriP-containing plasmids. Sal I sites in each plasmid are 
indicated by arrows. The sizes of expected run-off transcript(s) from each Sal I-
linearized transcription template are indicated by braces. Plasmids are not drawn 
according to size. 
 
The Sal I digestion products are shown in figures 13 to 16. They were purified using 
the QiaQuick PCR purification kit before use in the in vitro transcription reactions. 
The transcription reactions were done as described in section 3.8, with rNTPs used at 
400 µM and incubation done at 30 ºC for 90 minutes. Transcripts were extracted as 
described in section 3.8 and analyzed by Northern blot analysis using neomycin 
phosotransferase gene specific probes. The results of this analysis can be seen in 
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Figure 22. Transcription of pcDNA3.1+-derived oriP-containing plasmids in 
vitro. Northern blot analysis of transcription products using neomycin 
phosotransferase gene specific probes. Lane 1: parent vector pcDNA3.1+; Lane 2: p-
S-oriP; Lane 3: p-S-oriP.1; Lane 4: p-oriP-∆S; Lane 5: p-oriP-S 
 
 
Lane 1 contains the positive control pcDNA3.1+ parent vector. From figure 22, it can 
be observed that there are two very distinct bands in lane 1 upon probing with 
neomycin phosotransferase gene specific probes. This is expected as Sal I digest of 
pcDNA3.1+ yielded a template containing two promoters, the CMV and SV40, as can 
be seen from figure 21. The larger transcript is the run-off transcript from the CMV 
promoter which is roughly estimated to be about 2.5kb and the smaller transcript is 
the run-off from the SV40 promoter, which is estimated to be 1.2kb long. A similar 
1.2 kb transcript was also observed for p-oriP-S (lane 5). As there is no CMV 
promoter on p-oriP-S, only one run-off transcript is produced and that is the neomycin 
phosotransferase gene driven by the SV40 promoter. p-oriP-∆S contains no promoters 
and no discrete products were observed (lane 4). The expected 3.4 kb transcripts of p-
S-oriP and p-S-oriP.1 (lanes 2 and 3 respectively) did appear but at much lower levels 
than the transcripts from pcDNA3.1+ and p-oriP-S, indicating that transcription on the 
former two templates was much less efficient. Thus, the inhibition of transcription by 
oriP observed in vivo was reproducible in vitro.   
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4.4 Construction of templates for analysis of transcription arrest in vitro 
In the studies described above, inhibition of transcription by oriP was observed in the 
plasmids p-S-oriP and p-S-oriP.1, which have oriP occurring right downstream of the 
SV40 promoter and upstream of neomycin phosphotransferase gene sequence. In the 
Northern blot analysis, the transcripts were detected by probing for the neomycin 
phophotransferase gene sequence. Should transcription arrest occur at oriP, the 
transcripts resulted from this event would not contain the probed sequence and thus 
could not be detected. Probing for oriP sequence may not be able to provide sensitive 
detection of the arrested transcripts because the detectable region in the arrested 
transcripts could be very short, depending on the actual arrest site(s) within oriP. 
Nevertheless, the possibility of transcription arrest could be investigated only if 
sensitive detection of the arrested transcripts is achieved. To achieve this, a new 
plasmid construct would have to be created that has a sufficiently long sequence 
between the promoter and oriP, which is to be probed for in Northern blot analysis. 
That would also most likely enable us to determine the region within oriP that is 
responsible for inhibition of transcription. 
 
Thus, the plasmid p-E-oriP was constructed by inserting an oriP-containing 2.2-kb 
EBV genomic sequence into the vector pEGFP-C1 downstream of the enhanced green 
fluorescent protein (EGFP) coding sequence in the CMV immediate early promoter-
driven transcription unit. If transcription of this plasmid is arrested at anywhere within 
oriP, the resultant transcript will contain the EGFP sequence and thus be detectable in 
Northern blot analysis using EGFP sequence-specific probes. To accompany this 
plasmid, a plasmid (p-E-lacZ) was constructed by the insertion of a 2.2-kb partial lacZ 
           




HSV TK polyA signal
CMV promoter








ORF into the corresponding site in p-EGFP-C1. The relevant regions of these 














Figure 23. Map of pEGFP-C1. This vector contains two promoters, the CMV 
immediate early and the SV40 early promoter. The EGFP ORF is driven by the CMV 
promoter and the SV40 polyA signal is located downstream. The neomycin 
phosotransferase gene is driven by the SV40 promoter for selection purposes in 
transfected mammalian cells. Several important restriction enzyme sites used for 
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Figure 24. Map of plasmid p-E-lacZ. This plasmid was constructed by the insertion 
of a 2.2-kb partial lacZ-coding sequence into pEGFP-C1, between EGFP-coding 
sequence and SV40 polyadenylation signal. Important restriction enzyme sites are 
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Figure 25. Map of plasmid p-E-oriP. This plasmid was constructed by the insertion 
of an oriP-containing 2.2-kb EBV genomic sequence into pEGFP-C1, between EGFP-
coding sequence and SV40 polyadenylation signal. Important restriction enzyme sites 
are shown and their positions on the plasmid in parenthesis. For Nde I sites, only the 
first and last position are shown. 
 
4.4.1 p-E-lacZ 
For the construction of p-E-lacZ, pEGFP-C1 (Clontech) was digested using the 
restriction enzymes Eco RI and Apa I. The lacZ insert was excised from pTracer-
CMV/Bsd/lacZ (Invitrogen) using the enzymes Cla I and Apa I. Both vector and 
insert were purified using the QiaQuick PCR purification kit before ligation. After 
ligation, the products were again purified and subjected to T4 DNA polymerase blunt 
end repair. After repair, the products underwent a final round of purification and 
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Plasmids extracted from several successful transformants were analyzed using the 
restriction enzyme Nde I. After enzyme digestion, the fragments were analyzed using 
gel electrophoresis. In addition, p-E-lacZ was also treated with the following enzymes 
to generate different restriction fragments: Stu I and Bsp HI double digest; Stu I and 
Ssp I double digest. After enzyme digestion, agarose gel electrophoresis analysis was 
performed. Figure 26 shows the gel photograph of one positive isolate. 
 







                       A                               B          
Figure 26. Gel photos of p-E-lacZ restriction enzyme analysis. (A) Lane 1: 1kb 
DNA ladder; lane 2: undigested p-E-lacZ; lane 3: p-E-lacZ digested with Nde I. (B) 
lane 1: 1kb DNA ladder; lane 2: undigested p-E-lacZ; lane 3: p-E-lacZ digested with 
Stu I; lane 4: p-E-lacZ digested with Stu I and Bsp HI; lane 5: p-E-lacZ digested with 
Ssp I; lane 6: p-E-lacZ digested with Stu I and Ssp I 
 
From figure 26A lane 3, it can be seen that an extra Nde I restriction enzyme site was 
introduced by the lacZ insert, resulting in two closely migrating fragments, one 3.3 kb 
in size and a second fragment 3.6 kb in size. Stu I cleaved p-E-lacZ at a single site and 
generated a fragment of 6.9 kb as evidenced in figure 26B lane 3. As expected from 
the plasmid map (figure 26), a double digestion with Stu I and Bsp HI yielded a small 
400 bp fragment, a 1.3 kb fragment and a large 4.2 kb fragment as seen in figure 26B, 
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fragments as well as the smaller 500 bp and 360 bp fragments (figure 26B, lane 6). 
 
4.4.2 p-E-oriP  
For the construction of p-E-oriP, pEGFP-C1 was digested with Eco RI and Sac II. The 
oriP insert was also isolated from the original oriP containing plasmid as described in 
section 4.1.1.3, using the Eco RI and Sac II. After the reaction, both vector and insert 
were first purified before ligation. The ligated products were transformed into 
electrocompetent DH10B Escherichia coli. Plasmids isolated from a few successful 
transformants were analyzed using Nde I restriction enzyme. In addition, the plasmid 
was also subjected to a double enzyme digest using Stu I and Bsp HI. The gel 
photograph of one positive isolate can be seen in figure 27 below. 
 







                                      A                                                       B 
 
Figure 27. Gel photo p-E-oriP restriction enzyme analysis. (A) Lane 1: 1kb DNA 
ladder;  lane 2: undigested p-E-oriP; lane 3: p-E-oriP digested with Nde I. (B) Lane 1: 
undigested p-E-oriP; lane 2: p-E-oriP digested with Stu I; lane 3: p-E-oriP digested 
with Stu I and Bsp HI; lane 4: 1kb DNA ladder.  
 
As can be seen from figure 27A and the plasmid map (figure 25), digestion of p-E-
oriP with Nde I yields small molecular weight DNA that appear as a smear at the 
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of the expected 1.1kb fragment found between the Nde I repeats of DS and FR, an 
indication of the presence of oriP. In addition, the presence of an additional Nde I site 
within the CMV promoter resulted in an additional 1.2kb fragment that could also be 
observed in the same lane. The digestion of p-E-oriP with Stu I and Bsp HI also 
yielded the expected bands: a larger 5.1kb band, a smaller 1.4kb and 390bp band 
(figure 27B, lane 3). 
 
4.5 In vitro transcription of p-E-lacZ and p-E-oriP 
To prepare the template for in vitro transcription, p-E-oriP was subjected to double 
enzyme digestion with Stu I and Bsp HI as described in section 4.4.2. p-E-lacZ was 
double-digested with Stu I plus Ssp I and  Stu I plus Bsp HI to generate two templates, 
the unimpeded transcription of which will give a 1.1-kb and 4.4-kb transcripts 
respectively. The resulting transcription template of each plasmid as well as expected 
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Figure 28. Linear maps of plasmids. Linearized plasmids digested with restriction 
enzymes (indicated by arrows). Expected run-off transcript sizes are indicated by 
braces. Plasmids not drawn according to size. 
A: p-E-lacZ digested with Stu I and Bsp HI; expected run-off transcript: 4.4kb. If 
digested with Stu I and Ssp I, expected size of run–off transcript to be 1.1kb. 
B: p-E-oriP digested with Stu I and Bsp HI; expected run-off transcript: 4.4kb 
The EGFP ORF will help to generate a transcript at least 700 bp in length. 
 
After digestion, the reaction was purified and 300ng of each digested plasmid was 
used as template for in vitro transcription. Northern blot analysis of the in vitro 
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Figure 29. Northern blot analysis of in vitro transcription. The transcription 
templates were p-E-lacZ digested with Stu I and Ssp I. Lane 1: p-E-lacZ digested with 
Stu I and Bsp HI; lane 2: p-E-oriP digested with Stu I and Bsp HI; lane 3: Probes 
specific to the EGFP gene was used. 
 
Lane 1 is the in vitro transcripts obtained from using p-E-lacZ digested with Stu I and 
Ssp I as a template. As expected, in vitro transcription yielded a small molecular 
weight run-off transcript with an estimated size of 1.1kb, while p-E-lacZ digested 
with Stu I and Bsp HI (lane 2) yielded an estimated 4.4kb run-off transcript, also as 
expected. This shows that the in vitro transcription kit employed is capable of 
transcribing long templates. If transcriptional arrest did not occur at oriP, p-E-oriP 
digested with Stu I and Bsp HI (lane 3) would be expected to yield a run-off transcript 
similar in size to lane 2. However, it can be seen that whatever transcripts that were 
present in lane 3 were not full length transcript. A few conclusions can be drawn from 
the above data. Firstly, the presence of oriP clearly poses an inhibitory effect on 
transcription in vitro. Taken together with the inhibition of transcription of p-S-oriP 
and p-S-oriP.1 (section 4.3.1), these results show that the inhibitory effect of oriP is 
independent of the promoter. Secondly, the appearance of partial length products for 
p-E-oriP shows that it is transcription elongation, rather than initiation being inhibited. 
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The majority of the partial length products were roughly about 1 kb. It would also 
seem that transcription of p-E-oriP, after 1 kb was drastically reduced. Interestingly, 
the FR of the oriP is located immediately after the EGFP ORF in this construct. This 
would suggest that that transcription could be arrested at the FR region of the oriP. 
 
The data presented thus far show oriP blocks transcription elongation. There are two 
types of transcription elongation block. If the transcription elongation complexes 
dissociate under this block, the event is known as transcription termination. 
Alternatively, if the blocked elongation complexes remain intact, the event is known 
as transcription arrest (Wiest et. al., 1992). A terminated transcript, being free, is in a 
much smaller molecular framework than an arrested transcript, which is still 
associated with the DNA template, RNA polymerase and other transcription 
elongation protein factors. Therefore, transcription termination and arrest can be 
distinguished by size exclusion chromatographic analysis of the transcription products. 
Terminated transcripts will elute from a gel filtration column much later than arrested 
transcripts.  As mentioned in section 4.2.1, the inhibition of both replication and 
transcription by the presence of oriP in a transcription unit can be fully explained if 
oriP induces transcription arrest. Therefore, I intended to carry out gel filtration 
chromatographic analysis of the oriP-blocked transcription products to test if oriP 
actually induces transcription arrest. In order to achieve this goal, terminated and 
arrested transcript controls were first needed to calibrate the gel filtration column. For 
the terminated transcript control, purified RNA or the run-off transcript from any 
reaction could be used. However, the arrested transcript control would be harder to 
obtain because there has not been any DNA sequence known to induce transcription 
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arrest. To obtain that, I attempted to arrest transcription by providing insufficient 
amounts of substrates, the rNTPs. 
 
4.5.1 Transcription arrest under shortage of substrates 
In the attempt to achieve transcription arrest under substrate shortage, in vitro 
transcription reactions were done using Stu I and Ssp I digested p-E-lacZ as the 
templates and different concentrations of rNTPs. The results can be seen in figure 30 
below. 
 






Figure 30. Transcription arrest under shortage of substrates. In vitro transcription 
was performed using Stu I and Ssp I digested p-E-lacZ as the templates and different 
concentrations of rNTPs. Time of reaction incubation is 20 minutes. 
 
From the figure, at 0 µM rNTPs, there was no full length transcripts produced as 
expected. The 1.1-kb full-length transcript can be seen from 25 µM onwards, although 
the intensity of the band started to reach a maximum at 50 µM. This shows that the 
concentrations of rNTPs, 400 µM, regularly used in transcription reactions in vitro are 
vastly excessive. Reaction at 10 µM of rNTPs gave products that were smaller than 
the full length transcript. These small transcripts were most probably from the 
elongation complexes arrested at various sites due to shortage of rNTPs. The amounts 
of these arrested transcripts were much lower than those from reactions with higher 
1.35kb 
0.24kb 
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concentrations of rNTPs. This indicates that transcription initiation in vitro is much 
less efficient at these low substrate concentrations. Using 400µM of rNTPs would 
give us maximum transcriptional reaction rate, which may affect any arrest by 
“forcing” the polymerase to read through the arrest site. Therefore, the idea of 
optimizing the rNTPs is to obtain the minimal amount of rNTPs that would give a full 
length transcript. On the other hand, using too little a concentration of rNTP could 
“induce” arrest. From the results of the rNTP optimization assay, it can be seen that 
50µM rNTPs was sufficient. This, in conjunction with work done by Freund and 
McGuire (1986), which characterized human term placental RNA polymerase II and 
found that the Km for rNTP to range from 45µM to 62µM, justified the use of 50µM 
rNTP as a workable concentration for in vitro transcription reactions in this study. In 
addition, due to the fact that I had limited time I decided not to optimize any further. 
 
4.6 Size exclusion chromatography able to separate DNA/RNA according to size 
Home-made gel filtration columns were prepared, as described in section 3.9.1, to 
analyze the in vitro transcription products of p-E-oriP-derived template to determine 
if oriP induces transcription arrest. Before subjecting transcription products to gel 
filtration chromatography analysis, preliminary studies on the columns were first done 
to see if the columns cast this way were generally RNase-free and able to separate 
nucleic acid molecules according to their sizes. Thus, DNA and RNA markers were 
loaded onto the column and eluted into fractions. 10µl of each fraction were then 
subjected to agarose gel electrophoresis analysis. After electrophoresis, the gel was 
viewed under UV light and a picture taken. The results are shown in figure 31 and 32 
below. 
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Figure 31. Gel analysis of size exclusion chromatography using λ Hind III DNA 
ladder. Only fractions 10 and beyond were collected. 
 
As can be seen in the figure 31, the higher molecular weight 23kb band started to 
elute out from fraction 20, while the 2 kb band eluted out from fractions 24 onwards. 
The 500bp band eventually eluted out from fraction 34.  
 






Figure 32. Gel analysis of size exclusion chromatography of RNA ladder (New 
England Biolabs). Fractions were collected from fractions 20 onwards. Size of RNA 
ladder is indicated by arrows in kilo-base-pairs. 
 
As for the separation of RNA, it can be seen from figure 32 that the RNA molecules 
started to elute out from fractions 22 onwards. The 9kb band started eluting out from 
fraction 26 onwards, while the 5kb band started eluting out from fraction 28. The 2kb 
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From the two experiments described above, it can be concluded that the home-made 
gel filtration columns can separate nucleic acids according to size and be RNase-free. 
They are thus suitable for the analysis of transcription products. 
 
4.6.1 Unimpeded transcription 
With the success in size-separating purified DNA and RNA using the gel filtration 
columns, the gel filtration columns was tested further on the products of unimpeded or 
run-off transcription. The run-off transcription products were first prepared by in vitro 
transcription using Stu I- and Ssp I-digested p-E-lacZ as the templates and 50µM 
rNTPs, as described in section 4.5.1. An aliquot was taken after 20 minutes for input 
and the rest loaded onto a column and fractions collected. Northern blot analysis was 










Figure 33. Northern blot analysis of size exclusion chromatography of in vitro 
transcription. (A): size exclusion of p-E-lacZ (digested with Stu I and Ssp I). The 
first lane is input run-off transcripts. Only fractions 21 and later are analyzed. Each 
lane contains 2 fractions. 
 
As expected, the transcripts produced in this reaction were the 1.1-kb full-length 
transcripts (input lane) indicating that transcription elongation had proceeded to the 
end of the linear template. These transcripts eluted out from the gel filtration column 
Input 21    23   25    27    29   31   33    35   37     39     41     43    45 
1.35kb 
0.24kb 
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from fractions 35 onward (figure 33). This elution pattern was very similar to that of 
the 1-kb RNA marker (figure 32). In fact, run-off transcripts are thought to be free 
from the association with any other molecules. Therefore, these results show that the 
gel filtration column is functional in separating components from a complex sample, 
such as the in vitro transcription reaction. The input RNA may appear to be smaller in 
size than the eluted RNA but that was due to a misalignment of the film and the 
camera resulting in a slanted image.   
 
 
4.6.2 Column is capable of excluding artificially induced arrested RNA 
polymerase 
Another chromatographic run was done to determine how arrested transcription 
complexes eluted from the gel filtration column. To do that, arrested transcription 
complexes were prepared by in vitro transcription using Stu I- and Ssp I-digested p-E-
lacZ and 10µM rNTPs, as described in section 4.5.1. An aliquot of the reaction was 
then taken as input control and the rest of the reaction was loaded directly onto a 
column and fractions collected from 20 onwards. The fractions were analyzed by 
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                         input  21  23   25   27  29   31   33   35   37  39   41  43   45   47   49 
Figure 34. Exclusion chromatography of artificially arrested in vitro 
transcription. The first lane contains input transcripts. The numbers at the bottom of 
each lane represents the fraction number. 2 fractions were collected as one sample. 
 
As expected, the transcripts produced in the reaction were shorter than the 1.1-kb full-
length transcript indicating that transcription arrest occurred (input lane). These 
transcripts started eluting out from the column as early as fraction 23 (figure 34), 
much earlier than the similar size RNA species the RNA ladder (figure 32). This 
elution pattern is expected of arrested transcripts, which remain associated with RNA 
polymerase, DNA template and probably other transcription factors. This result also 
provides evidence for the capability of the gel filtration column to distinguish free and 
complex-bound transcripts, setting the stage for the analysis of nature of oriP-
dependent transcription block. 
 
4.6.3 OriP induces transcriptional termination, rather than arrest, in pEGFP-
oriP 
In vitro transcription was performed using Stu I- and Bsp HI-digested pEGFP-oriP as 
the template and 50µM rNTPs. An aliquot of the reaction was then taken as input 
control and the rest of the reaction was loaded directly onto a column and fractions 
collected from 20 onwards. The fractions were analyzed by Northern blot and the 
1.35kb 
0.24kb 
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Figure 35. Northern blot analysis of size exclusion chromatography of in vitro 
transcription. Size exclusion of pEGFP-oriP (digested with Stu I and Bsp HI). The 
first lane is input run-off transcripts. Only fractions 21 and later are analyzed. Each 
lane contains 2 fractions. 
 
 
Consistent with the results shown in section 4.5, transcripts of lengths between 0.3-1 
kb, rather than the 4.4-kb full-length transcripts, were obtained (input lane), indicating 
that transcription elongation was blocked within oriP. These transcripts eluted from 
the gel filtration column mainly from fraction 39 onwards. The elution pattern was 
similar to that of the run-off transcripts (figure 33) or purified RNA of similar sizes 
(figure 32), and distinct from that of transcripts in arrested transcription complexes 
(figure 34). 
 
The appearance of free rather than arrested transcripts points to termination rather 
than arrest, as being the probable cause of transcription inhibition by oriP. This result 
does not support the possibility that inhibition of oriP-dependent replication is caused 
by the arrest of transcription complexes at oriP. Thus, how replication is inhibited 
when oriP is located within a transcription unit remains unexplained.  










































5.1 Inhibition of oriP replication function is dependent on the presence of 
promoter 
From figure 18, it is clear that the presence of the SV40 early promoter in a plasmid 
bearing oriP inhibits replication. The oriP function was severely impaired upon 
placing it, in both orientations, immediately downstream of this strong and 
constitutive promoter. Inhibition of replication was still present but to a lesser degree 
when oriP was placed further downstream of the promoter. Several conclusions can 
be drawn from these observations. Firstly, inhibition of replication is independent of 
the orientation of the oriP within the transcriptional unit. Secondly, the further away 
the oriP is from the direction of transcription, the less inhibition of replication there is, 
indicating that the progress of the transcriptional machinery through the oriP most 
probably played a major role in reducing the function of oriP. This is in agreement 
with some of the observations in previous works done using other known replication 
systems (Tanaka et al., 1994; Haase et al., 1994; Pan et al., 1995). 
 
5.2 Transcription through oriP was inhibited 
From the Northern blot analysis of total RNA isolated from the transfected cells 
(section 4.2), it was clear that the transcriptional elongation complex was somehow 
prevented from reading through the oriP. This observation was further corroborated 
by a similar finding using in vitro transcription of the same templates (section 4.3). In 
vitro transcription of templates containing oriP immediately downstream of the SV40 




such an observation: transcription termination or transcriptional arrest. While 
transcription termination would not be able to offer much explanation about any 
possible interplay between transcription and replication, transcription arrest on the 
other hand, if it really occurred, could potentially help explain the observations 
obtained in section 4.2 as to why transcription could inhibit replication, and to such a 
strong extent.  
 
Based on the preliminary results obtained, transcriptional arrest along oriP seemed 
like a probable explanation. As arrest is irreversible, it results in complexes trapped 
on the DNA template, preventing the progression of other elongation complexes. This 
could represent a spatial obstruction that prevents replication preinitiation complexes 
from assembling at the oriP, thus inhibiting replication. The fact that transcriptional 
arrest occurred not only in vivo (both in the presence and absence of EBNA-1) but in 
vitro as well indicated that the DNA sequence was the main culprit in inducing arrest. 
This was not surprising as oriP is an A-T rich region, containing many repeat 
sequences, especially near the FR (family of repeats) region. And drawing parallels 
with work done by Kerppola and Kane (1990); one of the strongest known arrest site 
in the histone 3.3 gene contains a T-rich region. It was therefore highly be possible 
that oriP could also contain transcription arrest sites. 
 
However, it was not easy to use the plasmids p-S-oriP and p-S-oriP.1 to determine 
exactly where within oriP transcription got inhibited because the oriP was too close to 
the promoter and any arrested transcripts would be too short for detection. In order to 
solve this problem, elongation of transcription would have to be allowed to proceed 




the easy detection of any arrested transcripts. Two new plasmids were constructed: 
one involving the insertion of oriP downstream of EGFP gene (p-E-oriP; section 4.4.1) 
and the other involving the insertion of a lacZ ORF downstream of the EGFP as a 
positive control (p-E-lacZ; section 4.4.2). These plasmids were digested with Ssp I or 
Bsp HI to generate different size templates used for in vitro transcription to test for 
transcriptional arrest. An additional restriction enzyme digest with Stu I is needed to 
remove the SV40 promoter from the template. By doing so, transcriptional elongation 
cannot proceed from the SV40 promoter and no contaminating transcripts will be 
produced. True enough, transcriptional inhibition still seemingly occurred in p-E-oriP, 
as evidenced in figure 27. From the range of the molecular size of the smear, the 
majority of the inhibition of elongation seemed to occur at the FR region, with a 
minority of inhibition occurring at the DS region.  
 
One of the potential problems that could surface was the possibility that the 
concentration of rNTPs utilized during in vitro transcription. The recommended 
concentration of 400µM was for the purpose to ensure maximum reaction rate. 
However, it was unnecessary to ensure maximum reaction rate for this study. In fact, 
there was a worry that the high reaction rate resulting from using 400µM rNTPs could 
affect arrest in an unknown way or by “forcing” the polymerase to read through the 
arrest site. Therefore, the optimization experiment of minimum rNTPs needed for 
elongation to proceed to completion was performed. From the results of the rNTP 
optimization assay, it can be seen that 50µM rNTPs was sufficient. This, in 
conjunction with work done by Freund and McGuire (1986), which characterized 
human term placental RNA polymerase II and found that the Km for rNTP to range 




reactions in this study. 
 
One of the other problems was the need for a positive control to show that size 
exclusion chromatography was capable of isolating arrested transcripts cum RNA 
polymerase. From the optimization of rNTPs study, it would seem no full length 
transcripts was observed using 10µM of rNTPs, most likely due to the slow reaction 
rate. This low reaction rate, coupled with the need for the transcription complex to 
clear the promoter before the elongation complex is stable, could result in more 
transcription complexes undergoing abortive initiation. This also probably accounts 
for the low intensity of the smear observed for 10µM rNTP lane in figure 30. The 
preincubation step without the addition of rNTPs was necessary for ensuring 
synchronized transcription elongation. 
  
5.3 Something else other than transcriptional arrest causes replication inhibition 
As figures 31 and 32 showed, the column used in this study was capable of 
differentiating between arrested RNA transcripts and free RNA transcripts. Although 
there exist the problem of overlapping peaks but that does not present a major 
obstacle to this study as the interest was not in isolating pure free or arrested 
transcripts.  
 
Unfortunately, the results obtained from section 4.6.3 seemed to indicate that the 
partial length transcripts isolated from in vitro transcription of p-E-oriP (digested with 
Stu I and Bsp HI) using 50µM of rNTPs were free rather than arrested transcripts. 
Strong evidence for this stems from the fact that the elution profile was similar to the 




(digested with Stu I and Ssp I). What this probably indicates is that the transcriptional 
termination rather than transcriptional arrest probably occurred at oriP and that the 
hypothesis that arrest of the transcription elongation complex at oriP resulted in the 
obstruction of replication initiation had to be reexamined. But the clear inhibition of 
replication by the presence of a promoter nearby still meant that transcription could 
play an inhibitory role in replication either directly or indirectly.  
 
5.4 Passage of transcription machinery could prevent replication initiation  
It has been shown that the arrest of transcription on oriP that could have resulted in 
prevention of replication initiation does not occur in this system; rather, it was 
transcription termination that most likely occurred. However, transcription 
termination itself does not explain how it may affect replication so negatively. One 
more plausible explanation would be that the progression of transcriptional elongation 
complex along the template could inhibit replication and physical arrest of the 
machinery along the template was not needed. This was shown elegantly by Haase et 
al., 1994 and Pan et al., 1995. Inserting transcriptional termination sequences between 
the origin of replication and the promoter, they prevented the elongation complex 
from reading through the origin and thus reduced the level of replication inhibition. It 
is possible that this might be the case in this study, and the observation that 
transcription through oriP was inhibited may not be related to the interplay between 
transcription and replication at all.  
 
How can transcription elongation inhibit replication then? Two possible explanations 
exist: First, the physical collision between the transcription and replication 




the inhibition. This was shown in the prokaryotic system by Mirkin and Mirkin (2005).  
In that study, the authors showed that the replication fork progression stalled when it 
is within a DNA region which is being transcribed. They also showed that although 
transcription and replication proceeding in the same direction had no effect on one 
another, stalling of the replication fork occurred only if the DNA polymerase were to 
meet the RNA polymerase head on during elongation.  
 
In addition to the mere physical collision between transcription and replication, the 
positive supercoils generated by both transcription and replication (Liu and Wang, 
1987; Peter et al., 1998) as they met head-on could help further worsen the inhibitory 
effect of transcription on replication. This build-up of positive supercoiling, (termed 
“knotting” by Olavarrieta et. al., 2002) was an effect brought about by the head-on 
collision of transcription and replication and had disastrous results. A similar 
explanation could be provided for this study: similar to what was observed in the 
prokaryotic system, as the elongation complexes of both transcription and replication 
meet head on, inhibition of replication was severely impaired either due to physical 
collision and/or due to the positive supercoils generated.  
 
If head-on physical collision between the two machineries was the case, it would still 
mean that replication elongation in the same direction as transcription would be 
allowed to proceed to the end. And since DNA replication is bidirectional, it would 
mean that at least one molecule of daughter DNA would still be produced as 
compared to two, and replication would be 50 % of what it could be per cell cycle. 
From the results obtained in section 4.1.3, an estimated 10 % of pSV40-oriP and 




cells had undergone at least two to three rounds of replication (1 cell cycle for every 
24 hours) before the plasmids were extracted, the expected amount of replicated 
plasmid would be from the 10 % to 25 % range, which would also explain for the 
observed levels of replication in this study. Given that the expected and observed 
percentages of replicated plasmids were roughly the same; the possibility that 
physical collision between transcription and replication resulted in inhibition of 
replication should be included in future work.  
 
The second possible explanation could be that as transcriptional elongation complex 
progresses through the oriP, it prevents the preinitiation complex from forming, as 
was suggested by Nieduszynski et al., 2005, thus resulting in an overall inhibition of 
replication. The authors showed that transcription into known origins (ARS1 and 
ARS121) increased their dependence for Mcm2 to 7. This observation indicated that 
transcription elongation could also inhibit replication by preventing the formation of 
pre-replication complex formation. Further work would be needed to be done to show 
if this is really the case. 
 
5.5 Chromatin remodeling could also affect replication  
As mentioned in section 2.3.2.1, to initiate transcription, the nucleosome must be first 
remodeled such that access to the promoter is granted to the RNA polymerase 
holoenzyme. Certain transcription factors such as SWI/SNF, BRCA1 and even 
elongation factors such as Elongator and FACT, have been found to contain 
chromatin remodeling properties. Since replication also requires an initiation stage in 
which replication machinery needs to obtain access to origins wrapped in histones, it 




And in this case, transcription factors could well play a double role in not only 
transcription but replication as well. 
 
However, most of the works reviewed so far seem to indicate that transcriptional 
factors play a positive role in replication. As described in section 2.3.2, the Abf1 
binding domain in the ARS1 was found to play a positive effect on replication and the 
C-terminal acidic domain can be replaced with transcription factors from other 
organisms (Li et al., 1998). In fact, Abf1 has been known to be involved in the 
repositioning of nucleosomes near the origin of replication and has been also shown 
to be able to recruit Esa1, which is an essential histone acetyltransferase (Reid et al., 
2000; Lascaris et al., 2000). It could be possible that Abf1 facilitates replication by 
remodeling the chromatin structure near the origin to be more accessible to the 
replication initiation complex.  
 
However, an exception to this claim can be found in another known yeast replication 
origin ARS301. In its normal state in the chromosome, the ARS301 was described as 
an inactive origin of replication, incapable of initiating replication. When ARS301 
was taken out of its native context and inserted into a plasmid, the ARS301 becomes 
active and is able to induce replication of the plasmid. This ability could be negated 
by inserting Abf1 transcription binding sites near the ARS301 region on the plasmid 
(Kohzaki et al., 1999).  
 
Combining the observations in both works, there is no clear answer whether a 
transcription factor like Abf1 plays a positive or negative role in replication. It could 




origin. Take ARS301 for example: it could be that in the native chromosome state, the 
chromatin structure near and on the ARS301 region was arranged in a way such that 
replication initiation was prevented from occurring. But, when the ARS301 was taken 
out of the chromosomal environment and inserted onto a plasmid, the chromatin 
structure surrounding or within the ARS301 could have potentially changed to a form 
more conducive for replication to occur. As Abf1 possesses the ability to recruit 
chromatin remodeling enzymes like Esa1, the insertion of Abf1 transcription factor 
binding sites could have the potential to revert the chromatin structure of the plasmid 
back to a similar state found in the chromosome, or potentially change it to a structure 
inhibitory to replication.  
 
Similarly, the inhibition of replication observed in this study could have originated 
from the presence of transcription factors rather than the passage of the elongation 
complex through the oriP. This is highly likely as both promoters used to drive 
transcription through oriP are strong promoters. The CMV immediate-early promoter 
used in this study has been shown to contain binding sites for transcription factors, 
such as NF (nuclear factor)-κB, ATF (activating transcription factor)/ CREB (cAMP 
response element binding protein), SP1 and AP1 (activator protein) to name a few 
(Meier et al., 2002). Similarly, the SV40 early promoter is also known to contain 
binding sites for SP1 and AP1 as well (Lee at al., 1987). It could be possible that 
upon binding to the respective sites found on the CMV or SV40 promoter, these 
transcription factors could have influenced the chromatin structure by recruiting 
remodeling enzymes. And under the circumstances of this study, the chromatin could 





As described in section 2.2.1, oriP consists of two separable and distinct regions, DS 
and FR. The DS has been shown to be the origin of replication where the ORC 
assembles through interaction with the EBNA-1 protein, whereas the FR has been 
described as playing a role of a transcriptional enhancer as well as ensuring that 
replicated episomes are properly segregated to daughter cells during mitosis. However, 
it was shown that in certain established EBNA-1 expressing cell lines, the presence of 
FR in the oriP could in fact inhibit the ability of the oriP containing plasmid to 
replicate (Leight and Sugden, 2001). This observation can be related to the both 
positive and negative effects insertion of transcription factor Abf1 binding sites can 
have on the ability of different ARS to act as an origin of replication. Being described 
as a transcriptional enhancer element, it would be expected to find certain binding 
sites for transcription factors within the FR. Indeed, it was shown recently that 
transcription factors Oct1 and Oct2 can also bind to FR and activate transcription 
without the presence of EBNA-1 (Almqvist et al., 2005). It should be noted that there 
may exist other hitherto undiscovered transcription factors that can also bind to the 
FR. 
 
It could therefore be possible that the presence of a CMV or SV40 promoter upstream 
of the oriP could have interfered with the chromatin structure of the oriP, resulting in 
a configuration that was inhibitory to replication. Or the presence of more than one 
enhancer element (one from the CMV promoter or SV40 promoter; the second from 
the FR element of the oriP) could have resulted in a recruitment of different 
chromatin remodeling enzymes to each enhancer element. That could potentially 
result in a competition between the remodeling enzymes to shape the chromatin. 




level of inhibition, it could also mean that the position of the transcription factors 
binding sites may be vital in determining the chromatin structure. More work would 
be needed to ascertain this theory.  
 
5.6 Future directions 
As described in sections 5.4 and 5.5 above, there are two main other possible 
explanations as to how transcription can inhibit replication. The first possibility is that 
transcriptional arrest is not needed and the passage of the elongation complex through 
the oriP would itself be sufficient in inhibiting replication. qTranscriptional 
elongation can inhibit replication through the physical collision and/or positive 
supercoils generated when they meet head on; or elongation could prevent the 
assembly of pre-replication complexes, thereby inhibiting replication. One way to test 
these two possibilities would be to first insert transcriptional termination sequences 
between the promoter and the oriP in p-S-oriP and p-S-oriP.1 and study the effects 
these termination sequences on the level of replication inhibition. It would also be 
interesting to see if the distance of oriP from the termination sequences would have 
any added effect on alleviating the inhibition of replication. This could be done by 
inserting the oriP at different sites downstream of the termination sequences. Southern 
and Northern blot analysis to would have to be performed to see if inhibition of 
replication would still occur with the introduction of termination sites as well as to see 
if the termination sites would be sufficient to terminate transcription in vivo and in 
vitro.   
 
The second possibility would be that chromatin remodeling could have a role in 




enzymes can be recruited to the promoter or oriP, the presence of transcription factor 
binding sites within both remain a plausible explanation. Regardless of whether the 
binding of transcription factors to its cognate sequences result in the recruitment of 
chromatin remodeling enzymes; or if chromatin remodeling enzymes are directly 
recruited through hitherto unknown sequences, one of the first things to do would be 
to examine the nucleosome arrangement of the plasmids p-S-oriP, p-S-oriP.1, p-oriP-
S and p-oriP-∆S.  
 
One of the ways to determine nucleosome arrangement on the plasmids would be to 
utilize non-sequence specific nucleases such as P1 nuclease or micrococcal nuclease 
that are able to cleave nucleosome free DNA sequences (Chu et al., 1990; Telford and 
Stewart, 1989). The plasmids would have to be first transfected into EBNA-1 
expressing cells and incubated at 37ºC at 5% CO2 after transfection for 48 hours. This 
is to allow for any replication of DNA and nucleosome arrangement to take place. 
After 48 hours, the cell membrane would have to be lysed in a manner that the nuclei 
are left intact. P1 or micrococcal nuclease would then be added to the nuclei and 
incubated at a suitable temperature. After nuclease treatment, the transfected plasmids 
would be extracted and analyzed by Southern blot and probed the appropriate probes 
to determine where the nucleases cleaved the plasmid. One of the problems facing this 
experiment would be how to ensure that the nucleases can pass through the nuclear 
pore and into the nucleus to act on the plasmids.  
 
It would be also important to determine whether the inhibitory effect of the promoter 
can be pinpointed to a more specific sequence. From there, it can also be determined 




transcription or otherwise that could potentially play a role in chromatin remodeling. 
This can be done by breaking the promoter into smaller fragments and inserting them 
upstream of the oriP and studying the inhibitory effect any of them might have on 
replication. It would also be interesting to see if the replacement of the promoter with 
additional FR elements could also remodel chromatin and inhibit replication. 
 
5.7 Conclusions 
In this study, we have managed to show that replication is inhibited by the presence of 
a promoter upstream of the oriP. In addition, transcription through the oriP was also 
shown to be inhibited. Arrest of the elongation complex along oriP resulting in the 
physical obstruction of the replication machinery from assembling on the origin was 
thought to have occurred. This offered a novel explanation of the interplay between 
transcription and replication. However, it was shown through size exclusion 
chromatography that transcription was most likely terminated and the inhibition of 
transcription through oriP was most likely not related to the inhibition of replication. 
 
Two other possible explanations of the interplay between transcription and replication 
in this study exist. The first explanation is that the passage of the elongation complex 
through the oriP is sufficient in preventing the assembly of the replication initiation 
complex. The second explanation is that transcription factor binding sites could have 
recruited transcription factors that either have the ability to remodel chromatin or are 
able to further recruit remodeling enzymes. The existence of transcription factor 
binding sites on both the promoter and the oriP also suggest the possibility that 
competition between these two elements for the correct chromatin structure could 




in this system. Further work would need to be done in order to understand more about 
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Restriction enzyme reaction set-up 
 
Reagent Final concentration 
DNA Specified in text 
10X NEBuffer 4 1X 
Aat II 1 u/µl 
H2O q.s as specified in text  
 Aat II single enzyme digestion reaction mix 
Reagent Final concentration 
DNA Specified in text 
10 X NEBuffer 4 1 X 
BSA (10 mg/ml) 100 µg/µl 
Aat II 1 u/µl 
Eco RI 0.5 u/µl 
H2O q.s as specified in text 
Aat II and Eco RI double enzyme digestion reaction mix 
Reagent Final concentration 
DNA Specified in text 
10 X NEBuffer 4  1 X 
Aat II 1 u/µl 
Sac II 1 u/µl 
H2O q.s as specified in text 
Aat II and Sac II double enzyme digestion reaction mix 
Reagent Final concentration 
DNA Specified in text 
10 X NEBuffer 4 1 X 
 BSA (10 mg/ml) 100 µg/µl 
Aat II 1 u/µl 
Kpn I 0.5 u/µl 
H2O q.s as specified in text 
Aat II and Kpn I double digestion reaction mix 
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Reagent Final concentration 
DNA Specified in text 
10 X NEBuffer 3 1 X 
 BSA (10 mg/ml) 100 µg/µl 
Apa I 0.5 u/µl 
Cla I  0.5 u/µl 
H2O q.s as specified in text 
Cla I and Apa I double enzyme digestion reaction mix 
Reagent Final concentration 
DNA Specified in text 
10 X NEBuffer 3 1X 
 BSA (10 mg/ml) 100 µg/µl 
Apa I 0.5 u/µl 
Eco RI 0.5 u/µl 
H2O q.s as specified in text 
Eco RI and Apa I double enzyme digestion reaction mix 
Reagent Final concentration 
DNA Specified in text 
10 X NEBuffer 4 1 X 
Dpn I 2 u/µl 
H2O  as specified in text 
Dpn I single enzyme digestion reaction mix 
Reagent Final concentration 
DNA Specified in text 
10 X Eco RI buffer 1 X 
Eco RI 0.5 u/µl 
H2O q.s as described in text 
Eco RI single enzyme digestion reaction mix 
Reagent Final concentration 
DNA Specified in text 
10X NEBuffer 3 1X 
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 BSA (10mg/ml) 100µg/µl 
Eco RV 1 u/µl 
Sma I 1 u/µl 
H2O q.s as specified in text 
Eco RV single enzyme digestion reaction mix 
Reagent Final concentration 
DNA Specified in text 
10X NEBuffer 4  1X 
Nde I 1u/µl 
H2O q.s as specified in text 
Nde I single enzyme digestion reaction mix 
Reagent Final concentration 
DNA Specified in text 
10X NEBuffer 4 1X 
 BSA (10mg/ml) 100µg/µl 
Sac II 1u/µl 
Eco RI 0.5u/µl 
H2O q.s as specified in text 
Sac II and Eco RI double enzyme digestion reaction mix 
Reagent Final concentration 
DNA Specified in text 
10X NEBuffer 4 1X 
BSA (10 mg/ml) 100 µg/ml 
Sac II 1 u/µl 
Xba I 1 u/µl 
H2O  as specified in text 
Sac II and Xba I double enzyme digestion reaction mix 
Reagent Final concentration 
DNA Specified in text 
10 X NEBuffer 3 1 X 
BSA (10 mg/ml) 100 µg/ml 
Sal I 1 u/µl 
Appendix 
 130
H2O Specified in text 
Sal I single enzyme digestion reaction mix 
Reagent Final concentration 
DNA Specified in text 
10X NEBuffer 4 1X 
Sma I 2 u/µl 
H2O q.s as specified in text 
Sma I single enzyme digestion reaction mix 
Reagent Final concentration 
DNA Specified in text 
10X NEBuffer 4  1X 
Stu I 1u/µl 
H2O q.s as specified in text 
Stu I single enzyme digestion reaction mix 
Reagent Final concentration 
DNA Specified in text 
10X NEBuffer 1 1X 
Stu I 0.5 u/µl 
Bsp HI 0.5 u/µl 
H2O q.s as specified in text 
Stu I and Bsp HI double enzyme digestion reaction mix 
Reagent Final concentration 
DNA Specified in text 
10X NEBuffer 3 1X 
Stu I 0.5 u/µl 
Sal I 1 u/µl 
H2O  as specified in text 
Stu I and  Sal I double enzyme digestion reaction mix 
Reagent Final concentration 
DNA Specified in text 
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10X NEBuffer 2 1X 
Stu I 0.5u/µl 
Ssp I 0.5u/µl 
H2O q.s as specified in text 
Stu I and Ssp I double enzyme digestion 
In vitro transcription reagents 
 
Elution Buffer 
15 mM K-HEPES (pH7.9) 
50 mM KCl 
1 mM EDTA 
1 mM DTT 
0.2 % Triton X-100 
 
Stop Buffer 
0.3 M Tris-HCl, pH 7.4 
0.3 M NaAc 
0.5 % (w/v) SDS 
2 mM EDTA 
3 µg/ml tRNA 
 
Southern and Northern blot Reagents 
 
Alkaline Buffer A 
50 mM NaOH 
100 mM NaCl 
 
Buffer A 
100 mM Tris-HCl 
300 mM NaCl 
 
Denaturation Buffer 
1.5 M NaCl 
0.5 M NaOH 
 
Hybridization Buffer 
5 X SSC 
20 fold dilution of liquid block provided 
0.1 % (w/v) SDS 
5 % (w/v) Dextran Sulphate 
5 X MOPS Buffer 
0.1 M MOPS  
40 mM NaAc 
5 mM EDTA 
 
Neutralization Buffer 
1.5 M NaCl 
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0.5 M Tris-HCl, pH 7.5 (NUMI) 
 
Neutralization Buffer A 
100 mM Tris-HCl 
 
Running buffer; Northern blot 
To make 100 ml of Running Buffer, add the following 
20 ml 5 X MOPS Buffer 
12.5 ml 37 % Formaldehyde 
67.5 ml RNase free water 
 
Sample loading dye; Northern blot(10 µl volume) 
5 µl Ambion Sample Buffer (Ambion) 
2 µl 5 X MOPS buffer 
1.6 µl 37 % formaldehyde 
0.4 % Glycerol 
1 µl RNA sample 
 
20 X SSC 
0.3 M Na3citrate 
3 M NaCl 
RNase free water to be used for Northern blot 
 
NEBuffer 1 
10mM Bis Tris Propane HCl 




















50mM potassium acetate 
20mM Tris-acetate 











0.025% Triton X-100 
pH 7.5 
 















To obtain 10 litres of R10 media, add the following: 
1 X 10 litre RPMI powder dissolved in 5 litres of nanopure water 
35.7g Hepes 
3g L-glutamine 
1.1g pyruvic acid sodium salt 
10g glucose 
20g NaHCO3  
Adjust to pH 7.2 by adding 1N NaOH or 1N HCl 
Add another 5 litres of nanopure water and sterilize by membrane filtration 
 
R10 media 
Add the following to 500ml of RPMI to obtain R10 media,  




For 1 litre of LB agar, add the following to 1 litre of RO water: 
10g tryptone 
5g yeast extract 
5g NaCl 
10g agar base 
Autoclave at 121°C for 15 minutes, cool to 50°C before pouring into steril petri dish 
Store agar plate at 4°C 
 
LB + ampicillin agar 




5g yeast extract 
5g NaCl 
10g agar base 
Autoclave at 121°C for 15 minutes, allow to cool to 50°C before adding ampicillin 
Pour into sterile petri dish 
Store agar plates at 4°C 
 
LB broth 
For 1 litre of LB broth, add the following to 1 litre of RO water: 
10g tryptone  
5g yeast extract 
5g NaCl 
Autoclave at 121°C for 15 minutes cool to room temperature 
Store at room temperature 
 
LB + ampicillin broth 
For 1 litre of LB + ampicillin broth, add the following to 1 litre of water: 
10g tryptone 
5g yeast extract 
5g NaCl 
Autoclave at 121°C for 15 minutes, allow to cool to 50°C before adding ampicillin 
Store at 4°C 
 
SOC medium 
For 1 litre of SOC medium, add the following to 1 litre of water: 
20g tryptone 
5g yeast extract 
0.5g NaCl 
2.5mM KCl 
Adjust to pH 7.0 with 5M NaOH  
10mM MgCl2 
Autoclave at 121°C for 15 minutes 
20mM filter-sterilzed glucose solution 
Store at room temperature 
 
TE buffer 
10 mM Tris-Cl, pH8.0 
1 mM EDTA 
 
1.0 % agarose gel 
To 100 ml of TBE (NUMI), add the following, 
1.0 g agarose 
Microwave to dissolve agarose 
Allow to cool for 5 minutes before adding 5µl of ethidium bromide 
 
0.8 % agarose gel 
To 100 ml of TBE (NUMI), add the following: 
0.8 g agarose 
Microwave to dissolve agarose 
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Allow to cool for 5 minutes before adding 5µl of ethidium bromide 
 
1.0 % Formaldehyde gel 
To make 100 ml of gel, add the following 
20 ml of 5 X MOPS buffer 
67.5 ml of RNase free water 
1.0 g of agarose 
Microwave to dissolve agarose 
Allow to cool for 5 minutes before adding the following 
12.5 ml of 37 % formaldehyde 
